INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115201, 'inotuzumab ozogamicin', 'imipramine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115338/', '', X'789c3d8cc10ac2400c447f656f5e16bfa21705b5a0e839b6290dc4a464a36cf7eba539f436f37833fd8c82dc4830a7eecb5ad1233f0c64e5615d4c3f019ec4d074d42df760bbd861f9a1304c50a3dffd98ce3acba1a4979ae774c5691f9e8a0e606fadd068cce956c98d160789ffc09b7651c33ffb4e3802', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115202, 'inotuzumab ozogamicin', 'indacaterol', 'Moderate', X'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', 'DDInter', X'789c358fd14d04310c445b990296fba0051a0089067c896f63918d23c739b8ab1e671192bfec7933e3379a2eda2003c6498f835be60cb9e1ca4e2fafa05d9b0c1f2063ccb16e0d21bc4aa393fc162f502f6cc836f7012fe448d4d04dabb63d168c8fcfe09ced4ef582f720b985e7283a6b8e2850becb3277c560fe5aecd11d0767495441ee019c456fcbef01fee96ce19218e311523dfe934f4b690b743ec335a569766a3570b5419911d375958a1e3315d04096e7531a8fb1a1ca5e820d61fe5bdc28b4d2f60d9d6a173fbfdf2061bccf4a86109bc3cac3cbb1add7cc17b922afc6e465835a946d493b5f7e01be668bbe', 'Synergism', X'789c1d8bdb0d83300c4557b90bd00f5660824a5dc01037b10436b21dba7e03bfe7b1504f3185049c373b0ed6c205f2c5ca49d30caaa612192067f4b89d6284ab283de74fb2c1b2b1a378af816c94d84871baeda67500c6fb33be64bf687ffd01af652a58', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115339/', '', X'789c4d8e410ec2300c04bf9207e4131401e2d01b3c20725cba52125b2639f4f7241455dc6ccd6a34b364aee12d85ddd24c4265ef9e992921a2a065efa616b973c44e6e6923d1cd4c7676fadbcd87c9bb8ba2b0ae86f15c53aba01f399b64792510c80542f4eeae16aa897e250fc8714fbd6238d73d2f420791d21b3f3b304423', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115203, 'inotuzumab ozogamicin', 'infliximab', 'Major', X'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', 'DDInter', X'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', 'Synergism', X'789c558cc111c3200c045bb90a52469e993cd20006616b0212830419771fc63f7ff76ef71d9c49dcd029124f961d019fd7135bd1f8a58e505408daf1633fa07e2cc6b50e511bad7532e379edf5a4726361bfc276e828091ba1aab06ba784b89e544ee4e5ad2212cd25b7ba0468064ba6e8ac628f3f04b73cd0', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115340/', '', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', X'789c458d4b0a80300c44afe201bc849fb5146f90962c024d2b3129e2e985b6ea6edec09b71286ab731f8715850eda21aa782b1950e12a971830dc30f331608d4dd359f0a12bbcd54202954d8812d90f4012af91d46f692237de74c47f51f919d35ed', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115204, 'inotuzumab ozogamicin', 'influenza a virus a/california/7/2009 (h1n1)-like antigen (propiolactone inactivated)', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115341/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115205, 'inotuzumab ozogamicin', 'influenza a virus a/vietnam/1194/2004 (h5n1) antigen (formaldehyde inactivated)', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115342/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115206, 'interferon beta-1a', 'inotuzumab ozogamicin', 'Moderate', X'789c6d50cb6dc3300c5de50d106489ced00158898ed948a42b5275bd7d1927a7a22702c4fbbf19d52e2a1e83424c610b3e3808a2c163e161ead8255658ac3c4037d670dcd5764558c2ea2c8c95370a0bfb912271a0d381cd22a142c1482686f8fd21dee43b65443fe738ae7877fed77125cf272bc8ddca43a43e530c1a8c42cefe57ec92b7b459456fa01926bd4f7d2593100769857312f8c5abd4b30e1ad349ca364f70c142d2e6e00bdcfa19705fa5a4397f4d191925c752df1a699ca35d7f016e277a5f', 'DDInter', X'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', 'Synergism', X'789c258c410e02310cc4be32474ebc860f84ed2c0954cd2a4905fb7b8ab8da966f4a84e50bbe437948d9061bcf1927527df6863bb1f9486b0c36bc9563a192551563672c070962e64f5b29bc9481c38ba34c7a3fff672fffacbb3c164e5c78fd0244be2e43', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115343/', '', X'789c6dcd410e83300c44d1abf80061d1de8045d56655ae60ca80ac3a063981f313755510db2fcd9b68053ec26723d6911bbb057a2f0eddf0150bf4505e30f180c419813a4c725adc39503cb6cf6c4d755e920b27b1ba6b754056ac3fb3fb03e359ebaf4f6a7e2a17714ef01dfe0b4071', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115207, 'interferon beta-1b', 'inotuzumab ozogamicin', 'Moderate', X'789c6d50cb6dc3300c5de50d106489ced00158898ed948a42b5275bd7d1927a7a22702c4fbbf19d52e2a1e83424c610b3e3808a2c163e161ead8255658ac3c4037d670dcd5764558c2ea2c8c95370a0bfb912271a0d381cd22a142c1482686f8fd21dee43b65443fe738ae7877fed77125cf272bc8ddca43a43e530c1a8c42cefe57ec92b7b459456fa01926bd4f7d2593100769857312f8c5abd4b30e1ad349ca364f70c142d2e6e00bdcfa19705fa5a4397f4d191925c752df1a699ca35d7f016e277a5f', 'DDInter', X'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', 'Synergism', X'789c258c410e02310cc4be32474ebc860f84ed2c0954cd2a4905fb7b8ab8da966f4a84e50bbe437948d9061bcf1927527df6863bb1f9486b0c36bc9563a192551563672c070962e64f5b29bc9481c38ba34c7a3fff672fffacbb3c164e5c78fd0244be2e43', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115344/', '', X'789c6dcd410e83300c44d1abf80061d1de8045d56655ae60ca80ac3a063981f313755510db2fcd9b68053ec26723d6911bbb057a2f0eddf0150bf4505e30f180c419813a4c725adc39503cb6cf6c4d755e920b27b1ba6b754056ac3fb3fb03e359ebaf4f6a7e2a17714ef01dfe0b4071', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115208, 'isoetharine', 'inotuzumab ozogamicin', 'Moderate', X'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', 'DDInter', X'789c358fd14d04310c445b990296fba0051a0089067c896f63918d23c739b8ab1e671192bfec7933e3379a2eda2003c6498f835be60cb9e1ca4e2fafa05d9b0c1f2063ccb16e0d21bc4aa393fc162f502f6cc836f7012fe448d4d04dabb63d168c8fcfe09ced4ef582f720b985e7283a6b8e2850becb3277c560fe5aecd11d0767495441ee019c456fcbef01fee96ce19218e311523dfe934f4b690b743ec335a569766a3570b5419911d375958a1e3315d04096e7531a8fb1a1ca5e820d61fe5bdc28b4d2f60d9d6a173fbfdf2061bccf4a86109bc3cac3cbb1add7cc17b922afc6e465835a946d493b5f7e01be668bbe', 'Synergism', X'789c1d8bdb0d83300c4557b90bd00f5660824a5dc01037b10436b21dba7e03bfe7b1504f3185049c373b0ed6c205f2c5ca49d30caaa612192067f4b89d6284ab283de74fb2c1b2b1a378af816c94d84871baeda67500c6fb33be64bf687ffd01af652a58', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115345/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115209, 'isoprenaline', 'inotuzumab ozogamicin', 'Moderate', X'789c6d91c16dc3300c4557e100690e1da1bdf45a200b30126d1191c494949c7afb527682024d0f066c9afceff3f38d1abebc0246a54a3a73009ca5b2358380d59f6e04518c5e9432368a7055c952676c2c15648296083e4fc0b5912e9801abf7484333ee05b2981de19448941a07cc793d40108c85074577991bb704e24aea78aa0e6f09dbe6e08e7bc2145c41c97a6e5e73ff911b2f04344d147c7eb8e01a94d0dcb3b25d86d7c5b59543cfe820d5b4b654186d74e61e7960440da3af4cbec480ed52d663a4ea556ce908efd9cd6fbb80f15c79f28fda9e92f99b4a5aaf72c14c8e0409a1abff9e94bebabb72a95b72c2f97e8fc71150c9bb924f45f044aa68d9b84a414aa11abdeee7f1d43ce60fb9d1427a1861d96f1623aa3341f113c0981a810fd688346a9f77cae324a42e69abbf94fb8ea27bff3fcc6d92be0391178f3fb1c5db5f', 'DDInter', X'789c358fd14d04310c445b990296fba0051a0089067c896f63918d23c739b8ab1e671192bfec7933e3379a2eda2003c6498f835be60cb9e1ca4e2fafa05d9b0c1f2063ccb16e0d21bc4aa393fc162f502f6cc836f7012fe448d4d04dabb63d168c8fcfe09ced4ef582f720b985e7283a6b8e2850becb3277c560fe5aecd11d0767495441ee019c456fcbef01fee96ce19218e311523dfe934f4b690b743ec335a569766a3570b5419911d375958a1e3315d04096e7531a8fb1a1ca5e820d61fe5bdc28b4d2f60d9d6a173fbfdf2061bccf4a86109bc3cac3cbb1add7cc17b922afc6e465835a946d493b5f7e01be668bbe', 'Synergism', X'789c1d8bdb0d83300c4557b90bd00f5660824a5dc01037b10436b21dba7e03bfe7b1504f3185049c373b0ed6c205f2c5ca49d30caaa612192067f4b89d6284ab283de74fb2c1b2b1a378af816c94d84871baeda67500c6fb33be64bf687ffd01af652a58', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115346/', '', X'789c458d510a80201044afe201bc8460811f4557305c52d05d3183ba7d6b617deddb8199a7693daa4d01418a990a64a6eccbf34fc1917b5125bed448173a39cf9643dc0255c03da030468a217b70bd1a7b4195dfb078c02b7e82119062db4adc60f90d362d32fe', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115210, 'ivabradine', 'inotuzumab ozogamicin', 'Major', X'789c35cdd109c3300c04d0556e80d229ba40a10b28b61c8b267290e4946c5f2710d0d789bbf7ea8c6890704c46f948645912b8144ee10f446598f817ade0fdc1666d693a53485390e6d135a7cc18b735d1600799d523ea2a84950e4c0cd1644cce19bfca0ad9e9b444c7c7d1af5ca2225b9f7d8814b773f1833d876da7e5f907fdd7402b', 'DDInter', X'789c1dccd10dc2300c84e1556e0296e804482c6062b7b594d8e038456c8fc5e39d7e7d9b130f359d1994ea06dfa1173d83584df0d13cc1b18e893c29d1c8f00aef6e471d82fb036a297151c73c7d75c6212641bd7ff114d0e5cac2376cb4fe3c191712acd430dc343db42c0a4148f331c4aa87ee686eb535c9126b0a7456f15e1ac5fd00547d43ca', 'Synergism', X'789c0dc8d10d02410805c0565e053661052636f04e709704c1b0dc1abbd7f99c6b525e16b6bad896817cc2368fa258283ed61352e758e8c9c6838177a5678c7f286e7758b4d6a663cd3c5d3034b4e8fec5a1e04e1395cb0fe9d32676', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115347/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c458d510ac2400c44afd203f4124510fc5044f000d966d4c036b3a46bcf6f8a827f6f78c3cc545b70eda256c7e1e4ca05fd25b379a6f24ef740e2bd98629680d3310e373c459357a63ba252add92ea6e5cfd7600b7156e6f2193dd3970f121bf26fe70b8a6dbf0a031f94b233f2', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115211, 'inotuzumab ozogamicin', 'ivosidenib', 'Major', X'789c5d8fc10dc3300845576180aa7bf458a90b50436254c744805365fb92a6a74af8f2e5ff1edc367521eef284823ddf7086d5b4699f31443be8045119ee0f901e6c1bb62b3c2aab7148c1d6f60b14455aa48b879d9db74405cd9a01cedcc31381f135fcd8ff4c587007631f2d32032492908d81a7894bf6b153e6c5189d094cfc752cb625dba48c862932ab7bd445d08f9f6d901c1a354762c859f5909d281f9447678a51af1f7f3c611b', 'DDInter', X'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', 'Synergism', X'789c0dccc10d84400805d0567e05db8415986c032838438260189ccd76afd777784b109fea3a2aa9341c7140670c6571ddf0d3ea88ea92e0bcdb40752aece4b8322cbcbd2058bf502fc94986d1e33646139724b33f3601cd783ffe3ce43228cf', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115348/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c2d8d510a02310c44afd203f4120a7ef8212ce80562772c81b659d254969ede14fc9979300f6683da98a3d23b86aba8614a65e71777ca6805a9602494182e959b147c47e1c62950e2dd359aa830e946e64a3185918b5853563ae533fa11c3864cfd20f5f4e97ed2ffe629264a7de1ad79ef688b1fa2f8016b8f38da', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115212, 'inotuzumab ozogamicin', 'ketoconazole', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115349/', '', X'789c45cd310ec3200c85e1ab70002e5165c9d02c4d2ee002519e04383206a9397da143baf949bf3e6f944a8d5c90add990e1e9e218ac7914c7f28633e4e0ad993f5e788f35053d40177c4fa623b2f07faf48e194d020d6bcb8d446454907bcd6b8931f5deedd939cdef002a5138db49fdd1edf29fdb885257c0134463a27', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115213, 'inotuzumab ozogamicin', 'lactitol', 'Moderate', X'789c6d8f616ac3300c85aff24ed0430c7680c12ea03a4a6dea48415292e5f6933bbaf5c7c0602ce1f7bdef4d0fee289d49bcc90de4c8411fb7ee6c9b337446610b6a824e5f146d67c742270a8d35772e61dacf60747507c98426c598721b9561cdef2325d49c26469e559b44c6ec2c61ad6c9d0c6456cfa84ba3fc8e3541b9744406054f385a544cb6dd725429b02653b3f1207c7c62e4d94efd82f7974253f3d8ec4a521296a5fa360dcb7aae7aa7ce8335ea8ef74237617f8c2aed8c2bb3c07855fba53ff541d7613e7e9231eea287fc58ce54862566b5ff74c95d4bfbd379e9fdf44980cae51bb9b198fb', 'DDInter', X'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', 'Synergism', X'789c1d8cd109c3300c0557790ba4b334d00584fd1a0b54b9d87292f12bfa7907774f09a5c7440c4ab0e2d268a8631da99a04bea35bf72381d85f500f8e530cb3f56515bc398a4ea2c80aed8eabd13169efedc3aa25f719ffa72677d2c9f9f8012a912c23', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115350/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c4dcec10dc2300c85e155324097e00e08091670db476ac9b52bc741617bd2c281ebf7ac5f3ec98b57db488774371f394c8674a1ac285cd754aa3c29d009b1bc4549c2d14cbb3c90a9c06dfebfb7c673dfae24d690f7d64d3091521c7eae236f6e258ec2b73941a48a951d48f5f781393e7ac2393d', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115214, 'inotuzumab ozogamicin', 'lactobacillus acidophilus', 'Moderate', X'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', 'DDInter', X'789c558e516e03310844af32078872897ee518ac4db348bb60014eb4b70f6e3faafe0133ccbc2f9a29a69000f5970477bc77560cb74d2ca5d5dd1973097dbae813729e532de618ce11a4097388266b306a15651b07453d2377761ad71d8fc4491736feada1ed60a4815e26bdd257ee5fe50d83bc8679901fd712fa6c1968a649a2cb1cd4da4e6ee7d538b0d9b276915b81d4730a6bf9dfbbfdd0873c55bea5155cc5fde7e77eff006339635b', 'Others', X'789c158bdb0d02410cc45a990a68824a021bdd8dc425511e20ba67f9b42ddf659a6e6041d69ba50b9f530d91fea0379fdba762fe614dd20ef0bac6bc2622b54aace1095aab9562234d3d5e527b469f9a12dfdb0ffa5627af', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115351/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115215, 'inotuzumab ozogamicin', 'lactulose', 'Moderate', X'789c6d8f616ac3300c85aff24ed0430c7680c12ea03a4a6dea48415292e5f6933bbaf5c7c0602ce1f7bdef4d0fee289d49bcc90de4c8411fb7ee6c9b337446610b6a824e5f146d67c742270a8d35772e61dacf60747507c98426c598721b9561cdef2325d49c26469e559b44c6ec2c61ad6c9d0c6456cfa84ba3fc8e3541b9744406054f385a544cb6dd725429b02653b3f1207c7c62e4d94efd82f7974253f3d8ec4a521296a5fa360dcb7aae7aa7ce8335ea8ef74237617f8c2aed8c2bb3c07855fba53ff541d7613e7e9231eea287fc58ce54862566b5ff74c95d4bfbd379e9fdf44980cae51bb9b198fb', 'DDInter', X'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', 'Synergism', X'789c1d8cd109c3300c0557790ba4b334d00584fd1a0b54b9d87292f12bfa7907774f09a5c7440c4ab0e2d268a8631da99a04bea35bf72381d85f500f8e530cb3f56515bc398a4ea2c80aed8eabd13169efedc3aa25f719ffa72677d2c9f9f8012a912c23', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115352/', '', X'789c4dcec10dc2300c85e155324097e00e08091670db476ac9b52bc741617bd2c281ebf7ac5f3ec98b57db488774371f394c8674a1ac285cd754aa3c29d009b1bc4549c2d14cbb3c90a9c06dfebfb7c673dfae24d690f7d64d3091521c7eae236f6e258ec2b73941a48a951d48f5f781393e7ac2393d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115216, 'inotuzumab ozogamicin', 'lapatinib', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115353/', '', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115217, 'inotuzumab ozogamicin', 'lefamulin', 'Major', X'789c5d8fc16d04410804532100fb22f1c7d2258006f606998513306b6df6667df2c7df165dd57cf086fb5231d8f184812b19c893df83158b099ee1eaf6c01237f00d6a327cde41ac380ed41bdc277b70c940d5f30d8623ed629215afceb7d404ef5a003ed82a1b81d52afb63ff67fe4e09cea5d5192091941c0cbc6d3cba8f469d8f60cc1e18925fd7b0a3d9216329b628629e3577c1bc2e75915c1a8f44eaff189e7ec95ea85c446c9d62cddb0f2c17659a', 'DDInter', X'789c55515d4ec3300cbe8a1f4142bbc484780569173089db5aa4f6b09dc26e8fd36d1293f292c4dfaf8f8a7565610fc36015d0091a4db8f6c6023f1c0b682c6450adcf0eb160404181b3695399f381e0e3042c41b661035fb4b70a330919b676814f02dc942bd5031cb1ef1a28154af27349c4aac2a1c64986466054745d4912003c4151c93b074a407702f69cf8ee6c83ef3d2d9384df5517dc08a85109d382565967c3d5e1e9f5f8e6cfbbecedb75d8232e746cd01dd294f85da77176184910e227f00cf99f46c8c39ff89632afdb354deb8f6746fec5f3061c9047e80d3f218a0aae34cbb30cbd47d84b741f5d0f2cdbd688cb6e8b71025f865c88f7a579cb3a15e7754767dabfebaae152f495dd27296b3afeb761b49467999e3ba591ff0c13736096aff07c7f3ddd7dde8e10fd5b9c856', 'Synergism', X'789c0dc8d10d84400805c0565e0536610597d8000aee92205c58d6cb75aff3396b105fea3a2aa9341c71c2e4a46b9a3a7e5a1d515d129cb30d54a7c2418e6f8685b737049f0dea25799361f498c668e29264f6c72ea03b94859707b5672860', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115354/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c3d8c510ac2400c44af9203e41445fcb22a28fe8736c5c06eb2acb1747b7a63a1fd19667833f3149591564b8c7011e5703222743488d71045b855719a49b770b7d4725b44a143385171cb6d03af28ecbe677fb3528e3f8447e1c14577768d5f9bbe95d4ed9fcff6998e9d55fe011c77353c', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115218, 'inotuzumab ozogamicin', 'leflunomide', 'Major', X'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', 'DDInter', X'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', 'Synergism', X'789c4dcd510e02210c84e1abcc018c97f0240466972640372da0de5ef0455fff69be3e8a3a51b549579376421cc6a8b5b22526c881c2a38ca65512a1864e935f58e7c3f75dc315bab075c7332b82117198ad50de5ba4cccd2f2087c96ff99b96a03dd320b52edac77519ddd780d0123217ae5d5f1211cefde4f6ed532231691eee1f14b24c11', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115355/', '', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', X'789c458d4b0a80300c44afe201bc849fb5146f90962c024d2b3129e2e985b6ea6edec09b71286ab731f8715850eda21aa782b1950e12a971830dc30f331608d4dd359f0a12bbcd54202954d8812d90f4012af91d46f692237de74c47f51f919d35ed', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115219, 'inotuzumab ozogamicin', 'lenvatinib', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115356/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115220, 'inotuzumab ozogamicin', 'levosalbutamol', 'Moderate', X'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', 'DDInter', X'789c358fd14d04310c445b990296fba0051a0089067c896f63918d23c739b8ab1e671192bfec7933e3379a2eda2003c6498f835be60cb9e1ca4e2fafa05d9b0c1f2063ccb16e0d21bc4aa393fc162f502f6cc836f7012fe448d4d04dabb63d168c8fcfe09ced4ef582f720b985e7283a6b8e2850becb3277c560fe5aecd11d0767495441ee019c456fcbef01fee96ce19218e311523dfe934f4b690b743ec335a569766a3570b5419911d375958a1e3315d04096e7531a8fb1a1ca5e820d61fe5bdc28b4d2f60d9d6a173fbfdf2061bccf4a86109bc3cac3cbb1add7cc17b922afc6e465835a946d493b5f7e01be668bbe', 'Synergism', X'789c1d8bdb0d83300c4557b90bd00f5660824a5dc01037b10436b21dba7e03bfe7b1504f3185049c373b0ed6c205f2c5ca49d30caaa612192067f4b89d6284ab283de74fb2c1b2b1a378af816c94d84871baeda67500c6fb33be64bf687ffd01af652a58', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115357/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115221, 'inotuzumab ozogamicin', 'levofloxacin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115358/', '', X'789c4dcb510ac2400c84e1abec01f616da4745742f306653088444d2adac9ede166af56d3e7e6630ef20b19cce50a9d285d2e29ad341f654c29f18f5cb23eb9f8a9854bc5d39a70bacf92336156e017a918af1faea0a9b7ef98a3befb8cd14d0116dd9270ffe00999037ce', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115222, 'inotuzumab ozogamicin', 'levacetylmethadol', 'Major', X'789c6d905d6ec3400884afc2015a9fa30f7da9940b90057b51d74b04d8956f5fd651a4f4e775c4cc7ccc3befba7254a4a301160e0c86150f28b83903a9f3ab714b95e066dab42f18a21d7486a80c1f17901e6c3bb6092e95d538a4606bc70b14455aa58b87dd3d5f1215346d06b8700fcf088cacea8fecdf99278ab16f2d52032492909d81e7994bfab153eac5183d014dfc7380ed996d52b6865964568fa8aba08fcbb6918c1a3547caff186e3acaee51be11714f15a34ef0264b1d0b24ab8fd8f6df5698d80c1513eacae945772d72ee75befbfccc8f0147df5f8ce91bb9a9958f', 'DDInter', X'789c158dd109c3300c4457b909ba442728640161a9f18123055949e9f675ff8ef7e0dd33440f3a67a514c3116f0cbbe3b0eaa2df01695652860fab23aa5b42f3da27962f34719c19237c5fc0f0da402fcb5b0638d1c227d5d2f43fd7055dd9564e1f3ffa9a2dbb', 'Synergism', '', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115359/', '', X'789c73c94ccccd2f2ac8c8cc4bd551704c4ecc2d28ca2f4e2c0172c2128b52f3329373c0322e99c5a53969994589b93a0a7e8939b9a969a92061bfcce4fc12a0020091ff19a1', X'789c458b4b0a80300c44afe201bc44d5ad1fbc415ab20834166252a4a7175a3fbb79f3663614b5620cbeef4654bba8469731b672f574d837193043a007160ca4c60da6742a486cf71dd80249334eb1a4f89e1c538643a1c286ece5777312bc013d5b3559', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115223, 'inotuzumab ozogamicin', 'lisdexamfetamine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115360/', '', X'789c6d8e410a80300c04bfd207f41345af05c117049b62a069a4e4507f6f2d563c78cb0ec36e1c1f3b2a3065b4664196d42fa7c252517bf0b7105f6b9554a80349d64c10230e6d3f53abcb14401b98b1f20fd322f05d75852540a44c771d296dcf137ee00bce0f3d39', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115224, 'inotuzumab ozogamicin', 'lithium carbonate', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115361/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115225, 'inotuzumab ozogamicin', 'lofexidine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115362/', '', X'789c73c94ccccd2f2ac8c8cc4bd551704c4ecc2d28ca2f4e2c0172c2128b52f3329373c0322e99c5a53969994589b93a0a7e8939b9a969a92061bfcce4fc12a0020091ff19a1', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115226, 'inotuzumab ozogamicin', 'lomefloxacin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115363/', '', X'789c3d8ddd09c24010065bb902ae0923f8228a880d9c9b3df8607fc262246bf562e07c9b8181b9a3374d82d5726e36f0a00b08223b5392f81b51cb955f10c59edc5c52738395a9965353c2a88edcd7f00dcab53c025dd6c00cfb993f632c26b64fcac2f61f5d3cf80b95ea3434', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115227, 'inotuzumab ozogamicin', 'lomitapide', 'Major', X'789c4590d171c3300c4357c100ad97c86f976065da662391ae4825f5f665edbbe64377fa008107dc8ce6262a1e9d424c610baa3509da65663c2536586cdc412b6b38ee6a4f451844e751181bef1416f62345e240a303bb454a85829197e8e2f7d3561e6923fa35fa31e1e3155248f30d6770e5c789e1a983731f0d09a64ec948ce0ed2f98a94020fce68179f70abd9a150c54c41f0b1aeec91e914ffea25ff54ca68a35e4dc5d139915c3e2b8396483a0fdb77d13553d3bb658d6b82d7246fa01a9b8d753bcb55d3f53d2f1b4a52f3f7602d7f989d31f4dc6afa058be98656', 'DDInter', X'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', 'Synergism', X'789c15c9b90d80301004c0563624a2092a39e103af64380baf79ba07d299c9ba183bd860e964f3042e28b1515699fc8ffeeb456584b21fa821df452be541f66a0ac5cd19b67edc30f8f80275de200c', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115364/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c4d8e4b0e83300c44af9203e41215a5bbb2a02770901123e158724c049c9ecf862e67e63d699a49672ebe190932c7d06b592a1527478ee1c3594724233fa7b622d3b008a518debcbaa94f9be97a7b3fc8a3356c7852bbb343904eaa030d57f572b53ffcbac095679218be6a7c0069203752', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115228, 'inotuzumab ozogamicin', 'lyme disease vaccine (recombinant ospa)', 'Moderate', X'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', 'DDInter', X'789c358f314ec5400c44af321d20a1349c809e12d19b5d6763296b476b6fa4dcfe3ba0df7aec37cfdf1ba393ce954accc1033e5b630f473175a93c441b2aaf3c06edb0152795224a21a6a046a21ef8ba3aa38a3339636ac88e0f74d3d81cb44662334c6088ceffcb0449ef53cde7710c769793111b0f3aae053f7f1deca976a1b1e678df2ffc32a87651f1447245188ec4b1a6eee0c272deb2c54648b17bc7a4a6c01d1e3b15eeb9f92cc12b2f6d79c76a039f35f54c5ffcf9c3dbf20082976933', 'Others', X'789c25cccb0d03210c45d1565e05d9a48d2cd38005062c0d06f933d2741fa4acafeef90ec624cd4625d2d8e0d93b7b38ca5297ca26da51b9b1195d580d3795224a214b419d443df07926a38a33392335e4c21b73690c07b538ec89070cd1fc9f0792395397e7dec6ee723362b0d17e5e3fa8e13921', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115365/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115229, 'inotuzumab ozogamicin', 'macimorelin', 'Major', X'789c5d8e410e02310845afc2018c3771613217208599123bc5001d33b797aa2b13d8fcf0dfe3864576356ed2a1e0dce10c4fd3a67dc310eda02b4465b82f203dd80e6c57582a6729a4606be7058a22edd2c5c3be9d974405cd9a016edcc31381f131fcd8ff4cd8f104631f2d32032492908381d7954bf6b153e6c5189d094cfc311f3b926d5246c31499d533ea2ee8f3b20d92a9517324869ca74ed917e583887ba618f5fa06e48f617f', 'DDInter', X'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', 'Synergism', X'789c0dc8d10d84400805c0565e0536610597d8000ab74bc28261d1cb75aff3396b100f759d95541a8ef862d0a123524c1d3fad8ea82e09ceab4d54a7c2418e33c3c2db1b82cf06f592bcc9307b5cc668e29264f6c72ea03b948597070e952933', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115366/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c1dcd410ec2400885e1ab7080b94563d44557f502744a1d12060c32466f2fedf6ff7861315f394c0a4cb8efc44a052e9bdbab99f2e805eeba59fda1a6c0d389b4c0c3641d819d373a7c0867bcd1378b9ad0e70818690b55a76085363ae6cd15056bd83b69320faee6748e678a86b5999cffe7cc7f97323785', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115230, 'inotuzumab ozogamicin', 'magnesium citrate', 'Moderate', X'789c6d8f616ac3300c85aff24ed0430c7680c12ea03a4a6dea48415292e5f6933bbaf5c7c0602ce1f7bdef4d0fee289d49bcc90de4c8411fb7ee6c9b337446610b6a824e5f146d67c742270a8d35772e61dacf60747507c98426c598721b9561cdef2325d49c26469e559b44c6ec2c61ad6c9d0c6456cfa84ba3fc8e3541b9744406054f385a544cb6dd725429b02653b3f1207c7c62e4d94efd82f7974253f3d8ec4a521296a5fa360dcb7aae7aa7ce8335ea8ef74237617f8c2aed8c2bb3c07855fba53ff541d7613e7e9231eea287fc58ce54862566b5ff74c95d4bfbd379e9fdf44980cae51bb9b198fb', 'DDInter', X'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', 'Synergism', X'789c1d8cd109c3300c0557790ba4b334d00584fd1a0b54b9d87292f12bfa7907774f09a5c7440c4ab0e2d268a8631da99a04bea35bf72381d85f500f8e530cb3f56515bc398a4ea2c80aed8eabd13169efedc3aa25f719ffa72677d2c9f9f8012a912c23', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115367/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c458e410ec2300c04bf9207f00bce70e98d5be2986625c796dc44025e4f425b71f3ee8ebd5ecc139ac9252c5d9eb1722bf898f0d096d16b20348f6de85b543dc83d49a0e8c9f4979e741173e4615ce754f8850c1df2ce56df049d7756e56dc2ab743ad61f500adbfc60af3a91bf65ce5f65843f09', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115231, 'inotuzumab ozogamicin', 'magnesium hydroxide', 'Moderate', X'789c6d8f616ac3300c85aff24ed0430c7680c12ea03a4a6dea48415292e5f6933bbaf5c7c0602ce1f7bdef4d0fee289d49bcc90de4c8411fb7ee6c9b337446610b6a824e5f146d67c742270a8d35772e61dacf60747507c98426c598721b9561cdef2325d49c26469e559b44c6ec2c61ad6c9d0c6456cfa84ba3fc8e3541b9744406054f385a544cb6dd725429b02653b3f1207c7c62e4d94efd82f7974253f3d8ec4a521296a5fa360dcb7aae7aa7ce8335ea8ef74237617f8c2aed8c2bb3c07855fba53ff541d7613e7e9231eea287fc58ce54862566b5ff74c95d4bfbd379e9fdf44980cae51bb9b198fb', 'DDInter', X'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', 'Synergism', X'789c1d8cd109c3300c0557790ba4b334d00584fd1a0b54b9d87292f12bfa7907774f09a5c7440c4ab0e2d268a8631da99a04bea35bf72381d85f500f8e530cb3f56515bc398a4ea2c80aed8eabd13169efedc3aa25f719ffa72677d2c9f9f8012a912c23', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115368/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c558e4b0ac3300c44afa203f812a1a1bbd22eb2e952716c2c90a5e04fb06f1f275d75373cde0c336322ef042d8981053764f4c406a61855a846b08135d1e60c7c35505c49467cb7bed6d2e52acd145d099d2157f6da6ef5e3a46846815db95f1ccba00f64fb3fb924cdfb40069e8c87b65b9b0e94df8997267702b6e93af2', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115232, 'inotuzumab ozogamicin', 'maprotiline', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115369/', '', X'789c3d8cc10ac2400c447f656f5e16bfa21705b5a0e839b6290dc4a464a36cf7eba539f436f37833fd8c82dc4830a7eecb5ad1233f0c64e5615d4c3f019ec4d074d42df760bbd861f9a1304c50a3dffd98ce3acba1a4979ae774c5691f9e8a0e606fadd068cce956c98d160789ffc09b7651c33ffb4e3802', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115233, 'inotuzumab ozogamicin', 'measles virus vaccine live attenuated', 'Major', X'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', 'DDInter', X'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', 'Others', X'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115370/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115234, 'inotuzumab ozogamicin', 'mefloquine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115371/', '', X'789c1dcad10d80200c45d155188025d88044176842d126d086da1add5ef0efdcbc97d4f07206c318d274473b5163c8afd23274e239ed509165f81fc9e486e1b29c550e07a616c3e6ad4291677e3e746b2027', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115235, 'inotuzumab ozogamicin', 'meningococcal polysaccharide vaccine group c', 'Moderate', X'789c5d514172c33008fc0a0f48f399f60358221613093c0239e3df1739993693932476975dd04f21c0dc58d8bca3b30ae80d583039efe8942f70e75ae7a91dd40bf5071b81a8b0dc28583a0c764c89850c5c815b1ba236b6ad931965d8a22d891bb0c14a421d6b3dc0f046b00c8786072c11c24c134f4778b01740c87cc62a51096b1b8b6ece0debcba1eaca09c26353894079d07447715e341f3142e185e74057f81ea9fcc798862ca98e1c8aa2a17d1485823b45b7149448372fbc3f9db1d3ebcdb27e8c171cc075b6bd9cd6f5685bd17438c15a7519956522f57ed4b00ff93bb991e3a2959da2d031f3b9ff0b98363a09bdd068514c7fb2c26b81ac166f9b1f95b407ace6d495b39d717327d117e05db73779c05565fd0a7a8b6d0514eb8c622c0be38f3fdb5d7f0104abcdbb', 'DDInter', X'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', 'Antagonism', X'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115372/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115236, 'inotuzumab ozogamicin', 'mesoridazine', 'Major', X'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', 'DDInter', X'789c15ccc109c3400c44d156a60237e10a026940ac14ef802d05498921d5c7be7ddee1af217ad0599dd20c47bc70584552e547379cec89e86909cdcf56e8298d218e77c61ebe5d60783c416fcbafec60618417d5d2f4ce6b4d570e69d3e50f97132ac0', 'Synergism', '', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115373/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115237, 'inotuzumab ozogamicin', 'orciprenaline', 'Moderate', X'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', 'DDInter', X'789c358fd14d04310c445b990296fba0051a0089067c896f63918d23c739b8ab1e671192bfec7933e3379a2eda2003c6498f835be60cb9e1ca4e2fafa05d9b0c1f2063ccb16e0d21bc4aa393fc162f502f6cc836f7012fe448d4d04dabb63d168c8fcfe09ced4ef582f720b985e7283a6b8e2850becb3277c560fe5aecd11d0767495441ee019c456fcbef01fee96ce19218e311523dfe934f4b690b743ec335a569766a3570b5419911d375958a1e3315d04096e7531a8fb1a1ca5e820d61fe5bdc28b4d2f60d9d6a173fbfdf2061bccf4a86109bc3cac3cbb1add7cc17b922afc6e465835a946d493b5f7e01be668bbe', 'Synergism', X'789c1d8bdb0d83300c4557b90bd00f5660824a5dc01037b10436b21dba7e03bfe7b1504f3185049c373b0ed6c205f2c5ca49d30caaa612192067f4b89d6284ab283de74fb2c1b2b1a378af816c94d84871baeda67500c6fb33be64bf687ffd01af652a58', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115374/', '', X'789c4dcc410ec2300c04c0aff801f90445807ac80d1e103906564a62cb2487fe9e1650c56d57b3daa8557a7a6913ba0fd7d425d0ad0a1764348c1a681a5956475ee55216565bdcf56b87bf5ddc9f029d0c4dece9d8cab98c0efec9d1b5eaa380c1941839d06c9ebaab7d4eaed03d47757903837e3adf', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115238, 'inotuzumab ozogamicin', 'methotrimeprazine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115375/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115239, 'inotuzumab ozogamicin', 'metronidazole', 'Minor', X'789c7591416ec5300844afc201aa7f926e2afd0b50436254db444052a5a72f4ebae9e24b5e8d60de0c7e972ec1048481e0fbbab20744c580ce613a84f0471b43c7130c8ddb099b69d3b1e614c3c7136404db810d74b9246e5c72b3a091e86ad81ff0acacc621055b3bdfa0285297211e86213ae05ba282e6b201ae3cc2ef0405c74bd895877d6f911a2091841c095f96a43be0a0d48b317a9633f1af19ef486f93b2374c90593da376419f936d279918354762c8b7e984dd56be13f14815a35e758ca162f23e3965716d388f68bca9253d5199f52ffa5d71babcc26b29bbd9c467952de7ef1364f8697a1de7df673c7e014574a45a', 'DDInter', X'789cd30500002e002e', 'Synergism', '', 'Minor', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115376/', '', X'789c458d5d0a02310c84afd203f414fe3c2e88ee05d26e1607da666912504f6f1571dfe663866f66342cf492c2315ca8996cfd47335ba7fccc056dd0891f859aeef59512ffe1e6b95359c9469ef059899a94180ed0ea760fea2963f88cc32646aaf03a1c5829b9a1c5704465c3f2fd3aabd4dd3d49e737573e3e04', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115240, 'inotuzumab ozogamicin', 'midostaurin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115377/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115241, 'inotuzumab ozogamicin', 'mifepristone', 'Major', X'789c5d8e416ec3400845afc201d2dca48b4ab9001abe33a863b018eccab72f4e16952ab140e8f3deffd4055be84c37d0ca276de1c3ed49d9415f8f466a893878d4424ce2131f81c109a9b819e24e8f0e0fa4361ee3bc51739655ad98c1a96ef4a3d9c90b18c44f58ce82735263fb67fb935d4d02731ff9f28a68ea01c2b2a0d53f9bd4bd0578568faaff4dbed051ecd0b60f2e51443fb3afcaf34a8e5df4d2784c1650cde697ec8d9abb08acae9cfdfe0bd409662d', 'DDInter', X'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', 'Synergism', X'789c258e414e05410844af523b37c64b78021313d738e03449374c80fe666e2ff96e0baadefb1a6258fa235768969b40133b85c1a4f346390eb70a9f18f72571cefb90a58494ce99e2f9f23c1d1ea5e95373410d17958a55e2576b408cfd14f39d78df39d4ce9744dec6e14b5e9b41bcd45a21bae6f65ff21a12e0d867a206150eeadd76713b3b107c7c36a9241e3491c3f76434448266ab7f0be8e1cac26f7fae195731', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115378/', '', X'789c0bcdc92c28ca2c2e49ccd1517049cc4bacca0732fc8b0b527333d352f3527514821273f22ba06ca7c4aad414382fa028b1b824b5283f2f1500764a197e', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115242, 'inotuzumab ozogamicin', 'mineral oil', 'Moderate', X'789c6d8f616ac3300c85aff24ed0430c7680c12ea03a4a6dea48415292e5f6933bbaf5c7c0602ce1f7bdef4d0fee289d49bcc90de4c8411fb7ee6c9b337446610b6a824e5f146d67c742270a8d35772e61dacf60747507c98426c598721b9561cdef2325d49c26469e559b44c6ec2c61ad6c9d0c6456cfa84ba3fc8e3541b9744406054f385a544cb6dd725429b02653b3f1207c7c62e4d94efd82f7974253f3d8ec4a521296a5fa360dcb7aae7aa7ce8335ea8ef74237617f8c2aed8c2bb3c07855fba53ff541d7613e7e9231eea287fc58ce54862566b5ff74c95d4bfbd379e9fdf44980cae51bb9b198fb', 'DDInter', X'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', 'Synergism', X'789c1d8cd109c3300c0557790ba4b334d00584fd1a0b54b9d87292f12bfa7907774f09a5c7440c4ab0e2d268a8631da99a04bea35bf72381d85f500f8e530cb3f56515bc398a4ea2c80aed8eabd13169efedc3aa25f719ffa72677d2c9f9f8012a912c23', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115379/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c4dcec10dc2300c85e155324097e00e08091670db476ac9b52bc741617bd2c281ebf7ac5f3ec98b57db488774371f394c8674a1ac285cd754aa3c29d009b1bc4549c2d14cbb3c90a9c06dfebfb7c673dfae24d690f7d64d3091521c7eae236f6e258ec2b73941a48a951d48f5f781393e7ac2393d', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115243, 'inotuzumab ozogamicin', 'mipomersen', 'Major', X'789c458ec115c2300c4357d1045d823343f8a5869a36765eecb4747b5c3870d04dd2ff37a3b98a8a47a71053d803559a55eece8a436281c5c21df4640dc7aa7628c2203a8fc258b85158d85b8ac4894a279a45568582914b74f1f5badd64cf1bd1d7e8e784fb1f52e8ca70066fbc7f353c7b70eea322c5d4291dc9d9413aff9052e0c18976f1e90366ff4b4d', 'DDInter', X'789c5d55c96edc3810fd953a2680d23fe09391049883071820f30325b224959b22395c3a96bf7e5e499a6e7b0eb6292eb5bca5fc9d7bd314492bb1bf69154f3ad1aa39ad52aaec07dd767f6b5b28b5450ae5d42436e510365a24734b2dbda9239eb15de98b5ce6cb40eca4f1aa31e545e21371706949018b5593e792a2601d7d4978556d851f1e5340a0daa424f5d52e346d7d94e27a48bd9e29b0ff9e82eca7538f3387fbc1f3f79fa471d1515b2af8769b0ba9e654340a7d59745ec8a78adbf5eb1379ad3d4c5a787d2289deba0b1aa988938ce7169fe714b55a648da86a4261111f578d5ce553a655da925a91376ee82ce2dad18515873abf699c02af2bd02adbbddcd85d9054d50bb2de0c716a8563754573fb7f865c003c5730f369bb4803ca3b5c001c4c4c86771304b2eed1b89d2c6a98a9c7a707e1fb5e0a37461adcbe6944ca8a40a8fd5d83f496e201bf4bf1d64365a3b676b71057725c465ef95d321e0cb46c1ec749631d689260470ddbc6e98d03ca367138f54fa7808266f5df42fa2da06506725e1d9b0c1f19d0439a742c7ba090566d8c37584745a47804af0daf8c0e041d391c2a8abd15b56000bef69c83acf2b1f631b0bb9289b12e03b9853397c201cbb44e45b6817efcf1f379a02bdf78a02c316e256d0896341c690becb0818846459d7cbdd09f0fbb2cc81053a351f0515bf7fad93b2f3f5e1e8d9f86690b37401ae1919ac89810a37eb716909bb80db803f5830ab743119b99d2bc69b9a0d7b4a2492ffe427fe1cd111551da7fc93f18ba2ea9078f426f42554a5fe9f9e5ef819e7fe117872b9b6028039d8cb250c7d1333c0e08460d5afa088fac28b11b10b9289cd2ac6ea0beb348693ab21bf02762730f5c302f7cdf3b7f1c23163b970a14e4e428164099d67d778d028fe6c9f9ac0227b0ef8e9d7fedd5fa43f6dd9aa567fb34fce1df5ab96c17faa516f59c3db4f2f68037c06f900c6afd00f49e4523528b0586999d49abe1bac29e387aed651bf642568e7d62d70043797070d299ef34f075d7f88300a30c4cd60e1fafa9883d0066f15e274af140e90af115f2bc7d20f5246f94fbb406f255e47a9a08b3a6edc3d946fa64656e680271f01c2ddd2737559dcfa95bb715c36e7d20714c736ddb0733a2f7810a9b63b4b9e52404c5bf294c12196ac4df9b89733f03943a776867e5c06a222a18bd506db69efee9ec8b8938b35919ff0dae64bac0b5cc98ebb5a514ea41f92bf788cee4f22ff6ea7a31', 'Synergism', X'789c1dc9c90dc0200c04c056f699579a48255670c24a8011981cdde7f8ce2c329c56c00e0907bb06704366b5acadeb1fe3d3931e611eb5a19a6b714a4a37a2567173bbb842f6973b269d1f7ae92023', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115380/', '', X'789c4d8e4b0e83300c44af9203e41215a5bbb2a02770901123e158724c049c9ecf862e67e63d699a49672ebe190932c7d06b592a1527478ee1c3594724233fa7b622d3b008a518debcbaa94f9be97a7b3fc8a3356c7852bbb343904eaa030d57f572b53ffcbac095679218be6a7c0069203752', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115244, 'inotuzumab ozogamicin', 'mirtazapine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115381/', '', X'789c3d8cc10ac2400c447f656f5e16bfa21705b5a0e839b6290dc4a464a36cf7eba539f436f37833fd8c82dc4830a7eecb5ad1233f0c64e5615d4c3f019ec4d074d42df760bbd861f9a1304c50a3dffd98ce3acba1a4979ae774c5691f9e8a0e606fadd068cce956c98d160789ffc09b7651c33ffb4e3802', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115245, 'inotuzumab ozogamicin', 'monomethyl fumarate', 'Moderate', X'789c5d8e3d0ec2300c85aff246902a8ec1d68d0b44addb58adedc84e80de9e7442b07eeff791092d08b6404c4da8e663c7d22479aa84cb38deaf3007d740719bbdad3160e67f63d2b953b77757be78c08b6b86d54cbd42a4a9452bc529829f74f6ca41fb0f4b2b69df92748075724afd5c8fc339b6f325eb425365d3b87d00b647468d', 'DDInter', X'789c658fd10dc2300c4457b90110d3c0006ee3104b895d254ea1dbe38a0f84f8b39e4fefec5b610ccaec074813386759693d6019cdd41a7b392af26cd4c9f982247fc87ad06eafd87c3144b15a5b44c9c5144ff102f3c21dd2da541b73db3a8f213b9f867670fd61f460f5814231ab39166605ef5467d8d315777539ebfac7a9d97afb54c900ed2495961ad7ada6718738a9638e78b6d8ac29741132499c20199b4569c4af6f6f986648', 'Synergism', X'789c65ccd10dc2300c84e1556e00c4342ce0360eb114db55e214b23de109a1be9dbe93fe476174ca1c1364099cb3ecb44f7886bab9729459918752a3e01b925cc8dbd2e6eff5fc1862d85d37310a71c34ba2c0a37083a80ef33e8ea371ef72f2b7a093eb9fd1932d3a0aad6d1ed8980d7c521dab9eee1f123745f1', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115382/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115246, 'inotuzumab ozogamicin', 'moxifloxacin', 'Major', X'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', 'DDInter', X'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', 'Synergism', X'789c45c8c10dc3400805d1567e056e2215447203c4e05d240c118b1da7fbec2db779f308e2435d472595862376b459bbc54d9b4e278eb8fffe6875447549709e6da03a153672bc332cbccd2178ae502fc98b0ca3c7698c262e49665fbc047485b2f0f203216f2fce', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115383/', '', X'789c3d8ddd09c24010065bb902ae0923f8228a880d9c9b3df8607fc262246bf562e07c9b8181b9a3374d82d5726e36f0a00b08223b5392f81b51cb955f10c59edc5c52738395a9965353c2a88edcd7f00dcab53c025dd6c00cfb993f632c26b64fcac2f61f5d3cf80b95ea3434', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115247, 'inotuzumab ozogamicin', 'mumps virus strain b level jeryl lynn live antigen', 'Major', X'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', 'DDInter', X'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', 'Others', X'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115384/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115248, 'inotuzumab ozogamicin', 'naltrexone', 'Moderate', X'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', 'DDInter', X'789c5d544192d4300cfc8a8e4b55d80fcc8902aa3872e0038aad4cc43896b1e5ec665f4f3bb30b0b87a9b12dbbd56aa9f36315ea4dc816ca9cbccab365a127f595cc57a954cc25bb724a07ad52d8cded5903f115c78dda6a3d459a8578378d12e969952cfbf9b2359d93d0833c5e1f27e220ce9b662bb871214ec1564b58e4580d686dacf0e3d9121234970ac4362eb87a9fa5869eacb7d7d4387f31a08fe8d2f395d39fc0a7cf5f49f3aab3ba55ecc31192b5625551dbc3aad795a235dc6e1f2e14b5f5b468e5ed4292e3a83a69a62a410a9e0f7cbe5ad636903583d50262199b9b38984639796f1ceadbce91d95cc3b8a39921ef7b364382c108642e9481742f74f0c7cb8f9a97c4db06a1ebf1a7a2dc43126b03be0e7101e995730b558bff9fa054f48c9b6dff1e5771643e151d155b4633a26087aea0a5cb688aaf3a54d5087251310a236c6967644178d78c8ccd4fea2f9aa4bbe57b8382e5bda7c6e750f4b012370a5c67def8450a1e4cb41e1161d3dc265a248d90e378a8b77302eb315641e38592168d1f933d095a76a50d5c023bf8fcc5065d5b74ae2744b24d9df106eb4d0b2a874279a2acc0cbf714cd8130da86a99e39dda72d77af3a80a17eeba524d9e47d0573e270a331a86d9d28ac5cb8564e58dab6543926faf2edeba7896ebcf34445723eaa1d00334df7b4159638d00da7aa413e3cd277d0f8df3a71d7867b6ed4446eaff5621efcf49e65d205ad9183e4b94012c941fe1a939a5e5fcdd38e0d33bbb561e77766553fdee986f199a8f228483dac10783035585f5143667c0ef0bf0f49cfd802c2d73e94e5c4e089c7709013e482cb7f758e9844a7c243e9c8f546bd9efd2e0c7b36374bedaec54fee19950944401586256d7096dbd9e537ce38859fc3bdee761787f11d79fc0d1a0ebdd2', 'Synergism', X'789c1dcb410ec2300c04c0afec9113afe9075cb2c596ac38aadda4fc1ec475a4d994b89288035dbc4eded18965a588529e1851ec65e2fe81724845c56d2fc8fbc789d4b8bc6127648635362c65e7fccf4cdb9d78f0f905ed4626b3', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115385/', '', X'789c35cc610ac3200c86e1ab78002fd16e14f6a37357709aa1d0e61351a83b7d8da5ffde84273147db9153009356e6680e7ee487b8d83f5c946115316aae45da3236ad1631dc7abdbe3565fc88b57ac0d3a06fbbf5ed7536392a768f8c14c43c63683ec3ddb4ffa7139bf03216', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115249, 'inotuzumab ozogamicin', 'natalizumab', 'Major', X'789c3d8f416ec5300844afc2b295be7a896e5ba957200e49d0c760619c2a3d7d715475371a06e6f16e5aac72a006988353a154a313d8065ceb50eba335a7de33f2f8b3aaad433058f7c7dcca092b5913ecc10570cf1b1d58a165e6d6e184412b7c731ca01828fc332a2e50f1ca60c97156c641e0dc9f77b76e54824de7a12263cd32686efb44e193a00e09deaca080d0781a69a176a058961e17bc7c7d7ebc3e00a1d3494e72c1ca1d17b9999b4562314adadba4016bcd3c86f2fdc1c99ede3fc2e4996c8b23ebdb2f93717488', 'DDInter', X'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', 'Synergism', X'789c3d8cd10d03210c4357f100a74ed30502178e48909c486845a72f1f55bf6c3d3dfb59194e856381f404972299f28215280535f9cc4e09a2c8d6936c26a6784b5448ef53cde77d0f76278de387ba9db36d51af639fee64bb1b7948860d58541ee88bdb7f2b2f065dace1a8b4bb5a20312bd8835213af7c3ebea9524123', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115386/', '', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115250, 'inotuzumab ozogamicin', 'nilotinib', 'Major', X'789c5d8f516ec3400844afc201da1ca552a55c802e388bba060b5857be7dd9345f95e08311bc193e64588aca1734d4ea190ccdb4b1a6638ae93bf1c14a35c3e1364c1f4f196c83ec0c9f77104df613c70dee9dcd39a5e118d75b7190f662c70b053f921dacce1cf051c42804e6d3f9c5fecf841d2f708e39b234402249391978dbb8d53d2a95de9c3198c025be57b073a597360796917bbfb2ef82b136c7245936e681c45075d832fb43c5a4fab454cc7efb051d156a32', 'DDInter', X'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', 'Synergism', X'789c0dc8c10dc2400c04c056b6029aa002241a70b0b9b3e47891cf09a27b32cfb95374f7f4d525ed4cf08df4605fb7e1eb3dc19e56d03ac6424f69bc24f12906735c61783ce1d956a704d6e4118a616925113f6c0639e96a7afb03b969286b', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115387/', '', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115251, 'inotuzumab ozogamicin', 'nilutamide', 'Moderate', X'789c7d90c16ec43008447f85632bede63f2af552697f00193646754c8471dafcfde224bdf63a9a7933f0a975be3bdb0258c974e60ac4abc9862e5ac1331bae3b24acb09a96700f0dbe1e2035621b96091e99d5d8256129fb0d92222d52a5b99d901ff10c3a508051e02d10e8ff3161c11d8c5b2f1e1a2091b86c0cfc7c728a7c6c0d3d1963630293f60dfa842dd826a9178c22b3bc7b5e04db70964e326ad41a12c789b0ea283b51ad131d87a3e7093efe0ab5de8e61fceb411e0d647dbe4ba59ea236f65ef3cf33a58dd771a5c37cfc0e5634bf168dec5b7b8f359b962df2a399b4c54b861cf411b85cd30b9b9e9655', 'DDInter', X'789c558fd16dc3300c4457b9018a6cd1010a6401c6a26522322990b20b6f5f2af9680be84b7c7c77bc6f8c072baf3202b682b4b8555614ee2e270d31c5d8d8a95f88cd8e5692c742ceebd1da058ae07c05544934c684d16db00ea106977842143d4df915705e584ed10a9b5a143f6ae0a9f69d3986eed62c87d3f275cfcdc17e52bbe1b3f13272780d063dd47ca726e98cbfadcc533fb24c76379f3ed18432fbad9c577ccc1bd13989220b764bc2fc556805bf53f2bc22569df678d1fc1bfe3f4f430a3b97db0f926a7c08', 'Synergism', X'789c158deb0d844008845b990aece5121be05c5c891bd8007ab1fbc3647ecde39bf5607c5979970cd80ed2e6d659d178badc94628a3cd8693e88c3aed1aa8f8d9cf76b8c0714c1a506ea241af996312d595368c0254e886216a9ac80f3c6728b76d88b45f3ab074eb55ffd18a6dbb00a5fca67ad65b2df34963ff2d43f2c', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115388/', '', X'789c73cc4b2c2e29caafcacf49d551702bcd294b057213f34a74147c52e1e28eb99979f9e939a525a9251999b999294021d78ad45ca0d2c4bc54004a671929', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115252, 'inotuzumab ozogamicin', 'niraparib', 'Moderate', X'789c6d8f3172c3400845aff24bbbc91d327169553901d23216132dec008abdb7f74a69d331ccffbcc79751a9a212e994628aa7e40acb951db5f366b1b7e61c21bf0c7ab066a05247b31cb3508ead1634b7cdf481d1c36cca23e36e4fa4bd6491eca0085b8e78f923a8383572993f301d98d2a36d14290ba26b71ab8ccb74fbbe9ee769d907e8f491828df71fae42b87c4ef72b561a6a33b3c2b9991f0851b4f1ce699bceff61df61c15d45', 'DDInter', X'789c15c9d10d80200c45d155de042ee12455abbc4481b405e3f6c2dfcd3dabb460c9a0438e4ed7033c916952c5b8cd5f4d7d1f3de8652494486a783ebd8bb73ad5d91572690e5f7edd3c1ed3', 'Synergism', '', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115389/', '', X'789c458c4b0a80300c05afe201bc849f8d0bb5788367c922d05a8969114faf18c1ddbc0fe348345f3962adab8e349ffce21c2050ab9b42c1c861e3a7b430ec1cf8e389fc3fb454e0f973f6e95048306b13b96053bc6141cc9ec56e6312ba01e5dc3298', X'789c2d8d510a02310c44afd203f4120a7ef8212ce80562772c81b659d254969ede14fc9979300f6683da98a3d23b86aba8614a65e71777ca6805a9602494182e959b147c47e1c62950e2dd359aa830e946e64a3185918b5853563ae533fa11c3864cfd20f5f4e97ed2ffe629264a7de1ad79ef688b1fa2f8016b8f38da', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115253, 'inotuzumab ozogamicin', 'norfloxacin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115390/', '', X'789c45cdcb0980301004d05652409a081ec58ba68165ddc0603e12548cd51b23e2edcd0ec35a44cc74252f5a59d93271618f5853274e5684577b4e67f324fc0f6a81f76c02166244ad46380aa5b1a7f8d184150cef9b9f17e940d66a48596e07ef2eaa', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115254, 'inotuzumab ozogamicin', 'nortriptyline', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115391/', '', X'789c3d8cc10ac2400c447f656f5e16bfa21705b5a0e839b6290dc4a464a36cf7eba539f436f37833fd8c82dc4830a7eecb5ad1233f0c64e5615d4c3f019ec4d074d42df760bbd861f9a1304c50a3dffd98ce3acba1a4979ae774c5691f9e8a0e606fadd068cce956c98d160789ffc09b7651c33ffb4e3802', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115255, 'inotuzumab ozogamicin', 'ocrelizumab', 'Moderate', X'789c558ec10d02310c045b71011c42b40025d0402ef67116491cd90e28544f82f8f0b3acd99dbded04cd0864031fe7e57a3e2dc84ad109217697d49d2384e2bc0a7690a894f8dd7258e1c5be838c9802e7dc0a2d59b0a5e05cee20bfa758ab55c98c9f34151a6a3f0097981a4eee1f1a1e4031b239288a0eb798930aa3410e7d0695827dab40d91e13e4b28dc12cc58e1febfa4f19', 'DDInter', X'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', 'Synergism', X'789c5d8dd111c2300c4357f1044cc3026eed363a1a3b672770303de6974f49f79eee4d09b68772aa50201fe407b108269e35f5becc738d119a0937cae6eb12da9476b784681487a3124b8721a706ec242fe785cfeabcd10bb391cfa6f12fac8b5fcde37dfb0259153571', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115392/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115256, 'inotuzumab ozogamicin', 'ofloxacin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115393/', '', X'789c4d8b4b0a80300c05afd203780b75a91b7b81904678101b292ad5d35b143fbb9937bc365a2646ac5c4f8a800c76c543e56abcc927db68d4471bd19f7944043a4ca5b02c897867452c56cb2833a69bd664f9e241f83b94807bee2cc90927a232e3', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115257, 'inotuzumab ozogamicin', 'olanzapine', 'Moderate', X'789c0dcbc10985400c04d056a602fbf847c106c21275204c64372a5afdf7f80eef57e0c0a9e6bd8cc2bd7bedde91617aeda01ccdcee1032d28368b7830b889eb07158e9e91daac9842aef836e6055479bf2ca63f0f8f24ac', 'DDInter', X'789c15ccd109c3300c45d155de04d9a5b40b88f8118bc65290640c99becdef8573df3e0899d53db49489e0ee63d01af67f5637ac4e839f62b75c6a842666b2616975b49847a2ba142488aff932943f3889d70757f8e976c8b3da7e0c85293d', 'Synergism', '', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115394/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115258, 'inotuzumab ozogamicin', 'olaparib', 'Moderate', X'789c6d8f314ec4400c45aff2cbdd863b202849c5099c8cb5b198b147b6c332b7671251d259d6ff7ecf6f46a5894aa4538a299e923b2c7776b4c1d5e2e8dd3942be19f460cd40a3816e3967a19c5b2de86ed5f481d9c36aca33e36e4fa4fdc826394011b69df1f247a8d4c9657dc17252ca885e295236c4d0e2d618b7e5fdf37e5da7ed989c4b470a2a1f5fdc84707b5d3eeed8699aadcc0ae76e7e1244d1e737976c3aff43fd059ebd5c69', 'DDInter', X'789c454fdb7103210c6c652bb8269c4604e88c660031485c42f701fff84fb3ab7dbd68ba688318283d629c2037b450a721e1c07db0c57d6fe6573c433df3405d5cd4663facc9c3a03737b70b2fadbdb03342514d883a370ccb3a4b4260741eb78ebaddc811c8b848dbea9650b5792e0bc79fe9761e177e144d1de634fcdb6a5b4a41279793894c3b7f70d4670b13eea115992bb9167d4b84eb9f44f18548f30c0ceb8c7a44a721eec7cf22eaebfa0749026586', 'Synergism', X'789c15c9d10d80200c45d155de042ee12455aa3441dad082717be1efe69e9d7a88568883d210e704b9a0858c9a1c6b5b633f674f7925323432373c1f17f56e4b5d06836eaee1db0fbc091e65', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115395/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', X'789c2d8d510a02310c44afd203f4120a7ef8212ce80562772c81b659d254969ede14fc9979300f6683da98a3d23b86aba8614a65e71777ca6805a9602494182e959b147c47e1c62950e2dd359aa830e946e64a3185918b5853563ae533fa11c3864cfd20f5f4e97ed2ffe629264a7de1ad79ef688b1fa2f8016b8f38da', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115259, 'inotuzumab ozogamicin', 'oliceridine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115396/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c35cc610ac3200c86e1ab78002fd16e14f6a37357709aa1d0e61351a83b7d8da5ffde84273147db9153009356e6680e7ee487b8d83f5c946115316aae45da3236ad1631dc7abdbe3565fc88b57ac0d3a06fbbf5ed7536392a768f8c14c43c63683ec3ddb4ffa7139bf03216', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115260, 'inotuzumab ozogamicin', 'omacetaxine mepesuccinate', 'Moderate', X'789c65915d6e03210c84afe2036c72879ea02fbd800bce62156c04267fa7afd934d2267d4102dbe3998faf44303a819e400b0632bcb2105cd812a8256ac0a50cd13e6a6dd43b9fbdb741b9517e79c395c43a14bc014b6884aee9e3d0b8ff4c7196130563957e84cfdd22cceae71c0b387d743a53a3377d9505848635ad248c0be45ba9e9794189a0b56ab321dc8dc3cbb2afa789b9c31d69236fc19c77462f890482622c3c15dc40dc134854d0d4f4ead2f301ebed081f8fc096d036e96ff7ceabf0c9c5c55c7d8b7098b0fe13f4cd79444f2fe610b466dc7c3f202ed03032da16fbce51cf237a97a7f6f3ae99e3025dcb63ba251aee6e379c784d10b5fbbd4ff2c1c170d0194b39f669086323d1bfc2a4ba1b9f34fd4fd683f717b059c3bca59084d9c1bce91d7f01fc29dbd9', 'DDInter', X'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', 'Synergism', X'789c558bcb0dc23010445b9902104d50c9120ff14ab11dedae1dd23d26e2c26d3eef3da487b60a75481aea4cd0175a9185216fad44e91e7812fdfa2a7609650dc7911bb20cc2b8cc613bafa06362cd20c65fd7ba228c1265523834325a641ab4945e9bf77d37ba4ff1eb9593dbdf96acaf7e83d484a10b31682ef70fe9f1457b', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115397/', '', X'789c2d8d510a02310c44afd203f4120a7ef8212ce80562772c81b659d254969ede14fc9979300f6683da98a3d23b86aba8614a65e71777ca6805a9602494182e959b147c47e1c62950e2dd359aa830e946e64a3185918b5853563ae533fa11c3864cfd20f5f4e97ed2ffe629264a7de1ad79ef688b1fa2f8016b8f38da', X'789c0b482d2a29ad2acd4d4cd251702c4bcd81b00212f3324b4a73211cbfd46404c729b52c313913aac125bfb824b1282713a23b37b32c31af2411a227b32c1f66566a6e52517e0e4c8f736a6e6601580b00f41b2d3b', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115261, 'inotuzumab ozogamicin', 'ondansetron', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115398/', '', X'789cf34b4ccaccc9cf4bd551084ece2fc8cf49cccd04718280ac82cc92c4bc121d05c782a25418dba5283f0fa8232f3f07005d081511', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115262, 'inotuzumab ozogamicin', 'osilodrostat', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115399/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115263, 'inotuzumab ozogamicin', 'osimertinib', 'Major', X'789c5d8f510ec2400844afc201d4ab18132f800bed12b74b036c4d6f2fd5f8e3ef84796fb8ba2c6c215d1eb0e00e058733903a9f8d1b0613aca64dfb8c21da412788ca70bb83f460dbb05de05e598d430ab6b69fa028d292400ffb765e1215346b0638730f4f0446aafa8ffdcffc4c31f6d12233402209d918789ab8641f3b655e8cd173a0893f8f615bb24dca689822b3ba475d04fdb86c83e4d0a83952fec7b0ea21fba27c1071cf14a35ede23f46682', 'DDInter', X'789c554f416e043108fb8a1fb0da4facaa9e2bf5034cc2ce20253002d26a7edf646e3d01c6b6ec178d145348c0b958efac952be40d0be9ec292adbfa8e58b062723651ba45bf92072c0f76541f7b200f4a14529c6ecd749f00e3eb7bea92fd87da131faf4f905604fbe8e0c62527f54a8ec7649536aa4cd969491132fa039d76e5b5deb242addc701c365ac5c6e8a692e6bc8ef79c88a4157bffd76085a4f3ba4d4e76b12ad3ab5da8c317379d2967f97cfe018a35664f', 'Synergism', X'789c1d8bdb0d8030084557b913b8841398b800b668492c184a757dabbfe731530f3185343827ab95357386ecb026953d4465fb6c6f1f568c6613a57f7a240a2c0a3bb2f7a3210a0512292eb7d3f41880b1ace30bf69bcee90511ea291e', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115400/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115264, 'inotuzumab ozogamicin', 'oxaliplatin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115401/', '', X'789c2d8d510a02310c44afd203f4120a7ef8212ce80562772c81b659d254969ede14fc9979300f6683da98a3d23b86aba8614a65e71777ca6805a9602494182e959b147c47e1c62950e2dd359aa830e946e64a3185918b5853563ae533fa11c3864cfd20f5f4e97ed2ffe629264a7de1ad79ef688b1fa2f8016b8f38da', X'789c458c4b0a80300c44afe201bc84e2d60fde202d59049a166252a4a7575a3fbb7933ccdb50d48a31b8be1b3286965647d1be7ec40c9e1e58d0931a3798d2a120812aecc0e6491e976249e13d0d4c19a242850dd9c9bfedb7ee6c8639095e4bb4356c', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115265, 'inotuzumab ozogamicin', 'oxytocin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115402/', '', X'789cf34d2dc9a8cc492d4acfcf4d2d29cacc4bd551f0cd2cce2f28ca2f2ec9cfd15170459671c9cc83ca807821a94539990545a9c5c5997940b9d4e2dc7c280f0082ec20c1', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115266, 'inotuzumab ozogamicin', 'ozanimod', 'Major', X'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', 'DDInter', X'789c85544d6b1c310cfd2b3ab6b0595a9ad2434f69a090530984f6acd89ab1d8b135f5c72c9b5f5fc9fb31db8452187616d97a7a7a7a9a1f2f98388a878005925478264a506af34c1e38c18c9529d502991cf1c269049fdb58a006ace0506f649944c335103c3e694ea5bce0b4856fe4b01582e78cfee0307b46c0e4e1ee273c4fe27680990c56c6c42f5a2d73d9c180ae4a2e304836b413b89290d493ed103d813eb358ada230391c6a888c1ba899b046250c7bae01e4dc5e09d2260f2325ca384d8753afca962b637dd5eb3e4827e724b996b3c634a343ebc50ebc525b15e907bb24fb74a1245a909d5d9d292b78d9c29d5fd8110c59222074591467e452cf2495569136860a3cfcb3212ec6aeb0a7fc9abcdd2baca20eacf3a96f647cf7f8e4bec3d8dbc936c704b79f3f402ce40c28e2a4a2aafcb75fd6e0403dfc7eb3d651a4551f9b7ec6f9f01f75f0a44f1fb50ce76996eb716ae52b879549f610087385ac7ced54fda3857d73d6cdc6226fda5f2d61c6fddd381b91575ade4f580a7c444338fe7f78785093a921cee90e7034d42ddc6bab12b99aa0666a257f99c5b1a4e6259259812abb0d708c2d4969f39ca9145ee8c8d4a274a3596d52c64aea58e06af6b8884ed5033a276a0ee32d6a88a827ad06c96c3efa0a41f6b450565493fefa0c502da61475fb2e6be326d14814b5bb742d7ceb2f27e8a32e41a979dd31dbbd365bd94f965283420e47af10587fe0e56f09b6f02bd877439570c170bbbdaf067fb28359b52b00340ce4b46f2d7206d974fc80d37033f1409d8a867b21ecc3ee9609a4b58fd0b195bec5579ba0785d4068c9ec94ba92deab300bbd9dc985c63ef0a415bb8fa1a08a5d597f4c9ac82fd6d1d9b25ea5c5621f2ee3b474d5b67f004d10f4f5', 'Synergism', X'789c0dcbd10980300c45d155de04ae22820bc426b4014d244dfbe1f4f6f772eefe91e9e38c461de6894bc4d073b00a430d2fa58a654748119d6a151ca37664a344a125c26f5f399be038d7931293eeed07136f2198', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115403/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115267, 'inotuzumab ozogamicin', 'palifermin', 'Moderate', X'789c558f314e44310c44af3207582810151d05c54a8802217a9378f9969c3872fc77f56f8f53a1ad2c4f9e6726e78fafb7cfefd7f7179c3b0845a54b2145b8909e40b5a530c329c43aec82412a17f6947193d8723c3d63b3dde77a2d1b378b8d9dc601e7b96b704542d28b33cd5c265fd9250e50afa8fbbfb379e6b6bdd8949079c258f78d7ef4488c117667d217755d3e799a89c848a98b4db54aff058fecc79aff4061d5b96a2c505ae32a148c61331eee2a8fac66f5f10f5e4e6738', 'DDInter', X'789c65cc410a02310c85e1abbc030c2ec48378853a4d6ca04d244dd1b9bd01c1cd6cdffbf8efa50b930f51cc66ab57a8051e8452739319e454f1966829ae37a4f1993f9bd386ba5cf409515e534c61bcc1fcc40b67e65ff4123f8b7150b7b08fecd81b0d8b465e5ec7e50b10503742', 'Others', '', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115404/', '', X'789c158dd10dc3200c05576100b66854b552dace601cd35a051c3910914c1ff3fdeedd3d8e45a50b4a8004998b7777c9b4f22989bc7bae8480debdb9aab4cd01f2e2dd445de1940ec5904f3fbe64b7194afd4169d921689002d5c6892325fe538434d437098cbc55a84312c9caa369e04cbb051bca2e3ac897285d4dcd38c8', X'789c458cd10980300c4457e9002e21fa2b169d202d41024d0b3129e2f4822dfa77ef78771e45ed368630b809d52e7ae35831b5d24326356eb006caf6f973391524f5055385acf0c2066c91a469a3e25d12f591470ef2e30e91faa13b4a25c50879704b117c0073533961', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115268, 'inotuzumab ozogamicin', 'paliperidone', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115405/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115269, 'inotuzumab ozogamicin', 'panobinostat', 'Major', X'789c5d8fc18dc34008455ba1804d6ad94869801d7006ed182c601cb9fb6025a71cb87cf1df835f54fb13b5484c68a8353318c8822fc41b2bb1266c6ec3f48129a6600b6467b8dd4134d9771c57b87736e79486631c3fd00c691595487f779e921dac6a0ef8286214e223fcb0bf99b0e201ce314756064824293b032f0bb7eaa352e5cd1983095ce2ff3c6c2fb64b9b034be4de8fecab609c9b63929c1af340aa0f19363b656f544caa4f2bc5ecd717671567b0', 'DDInter', X'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', 'Synergism', X'789c0dc8d10dc2300c05c055de042cc104482ce03626b1e4fa558e53c4f6f43eefc9d879584914d654f08353829b056749e16b35c01a9a68b9fa448d7b77099c4967f43b14af372c4af312c71c5cded03534c5fd874d2117ad697bfc01fce32909', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115406/', '', X'789c458c4b0a80300c44afe201bc849fadda2ba4258b40d3424c8af4f482adba9b37bc1987a2568dc18fc3826a173d712a185be920911a37383c25fbfc190b04eab063f8bd359f0a12fb175381a4d040b1e6f88e1cb2971fb72c78033d8c3564', X'789c2d8d510a02310c44afd203f4120a7ef8212ce80562772c81b659d254969ede14fc9979300f6683da98a3d23b86aba8614a65e71777ca6805a9602494182e959b147c47e1c62950e2dd359aa830e946e64a3185918b5853563ae533fa11c3864cfd20f5f4e97ed2ffe629264a7de1ad79ef688b1fa2f8016b8f38da', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115270, 'inotuzumab ozogamicin', 'papaverine', 'Major', X'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', 'DDInter', X'789c4d4fdb6d0341086c8502ac34910a2ca5813916fb50f6c062d98daefbe0fbf21f302fe61b33d58d608db8fb103adc343dd49e8410425b3aa4519bd7492d03ece186380b3cd474d4e932f107bdf0c292a2caade648e5d911fd2c61eda96239288445d7db8eddd80f4d58528bf91c943b9218c50eef5e94dc85ee3fef6089854e1e05cf7a740bb493114d71bdff99f0a7b99397342874fcd2035c9d0635191cba551f6cbee4eb1f781f602e', 'Synergism', '', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115407/', '', X'789c558e4b0ac3300c44afa203f812a1a1bbd22eb2e952716c2c90a5e04fb06f1f275d75373cde0c336322ef042d8981053764f4c406a61855a846b08135d1e60c7c35505c49467cb7bed6d2e52acd145d099d2157f6da6ef5e3a46846815db95f1ccba00f64fb3fb924cdfb40069e8c87b65b9b0e94df8997267702b6e93af2', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115271, 'inotuzumab ozogamicin', 'pasireotide', 'Major', X'789c2d8fd18d033108055ba180536ab993d2c08b616314af89006fb4ddc7ce45829f2798815f84ba582a0b15f4d923846e0e3e0b9c1584cef477a5a75bb37e47aaf50b5dab984b6a416be70f1503efda35d23f03f4d2ac6459c50977e9199415f9317c413390c5d59ee2071aed38c92546cb99119835f510926d9332f7d719da8b0b42985ce341b6d131d9ae65344c917b3db3ee8a58936db02e8d79603e37eb694bf68f8ac12c7da6c87a7903f4296196', 'DDInter', X'789c5550416e04210cfb4a1eb09a4facaaf65aa91fc84076262a10948456f3fb0deca53d418c6decdc71384b0336504a522bb54c19f8011d8d95c439d37c1d36e106c1d9b9e112fdb29f207e9242d67118f8890e091b749522ed0880e0f32b744efa836583b7fb3b60cb60a4a302154a1ed4cbc96ec14a65640e591747331ef506158f46f3ba64094b5ab09d324a869da04a6317a5393ce20473545f2e7f1acc90d8af65d24959328757b9200f9d5c57428ff23e3b624aa2195ba257c5d9221ae5911c0aee5442b1c1c7d5e51b0b55c6657bc6fc4abba03acc67beb08acd7ae4ebf1ad82cbbf60982b3736d7b5d2ed097b5095d2', 'Synergism', X'789c1d8bdb0d8030084557b913b8841398b800b668492c184a757dabbfe731530f3185343827ab95357386ecb8a889b38564fe6c6f1f568c6613a57f7a240a2c0a3bb2f7a3210a0512292eb7d3f41880b1ace30bf69bcee9050e0d2912', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115408/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c3d8bc10980300c0057c900d9424a3fa233041b35101248f3707cab88bfe3b85b3c384fe9c9e1c6080bed14ac6208eb96c19ed2862e4a87ab5c081367f8530c2e3d839ab8225432f9ec4cf67fd58dda9bdb0d2b6b26f5', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115272, 'inotuzumab ozogamicin', 'pazopanib', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115409/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115273, 'inotuzumab ozogamicin', 'pegfilgrastim', 'Moderate', X'789c8590414e03310c45afe2252cda03b043155448c08256ecddc433b194c4a3d8d3616e8f3354b06467cbdfcffffbe5fdfcf4f1f9f8fa00e744a03890ad8035020d03070c2bc800890a9a4cc2641c606cb2588201834953d0392440852059eaba53e3326734aee3afe4eeb83b9c9e37ecf1ad97f75bad460502e5fc273c1d7c36f2952a68e718569259f30a0bfbcd80355083e086c412359c56487825a8627021df2235bc64d64471df2349eb9e31bbbdbe5a15e88bd5a0d1882d7693cee1b68da5b0df33c058b8baa8790aa9ce0d382bfdf3855b6c82b252168e3fc1a6269907ba9196c4993cba3f8764caa81d842355535772c1c69ed4b08de40e71e2e86de42b6f463b50f7df9c43a111', 'DDInter', X'789c1d8fdb6905310c445b99024220e156904e145bf60a6c6991e50bee3edafccee330f3c385f66258435c8cdb8235840616eb9290b7c4794ca75bea38a8a954d18e79789854141e63210c85b4b0a35c3c2d5159381fffcc49ba1b95d89eb673b139596b762e0adcdc9b8ceeb44226d402bf8c2e6f5634b789af172a9d956a3367ec1c37f0fdc265db17a84532a94e5159e11462faaca58c29db3d1e6c01f53cb53eff00fae05832', 'Antagonism', '', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115410/', '', X'789c6dcd410e83300c44d1abf80061d1de8045d56655ae60ca80ac3a063981f313755510db2fcd9b68053ec26723d6911bbb057a2f0eddf0150bf4505e30f180c419813a4c725adc39503cb6cf6c4d755e920b27b1ba6b754056ac3fb3fb03e359ebaf4f6a7e2a17714ef01dfe0b4071', X'789c0b482d2a29ad2acd4d4cd251704e2d29adc80433fd73128b124b20c28e65a93910966b4e3e5c714851623194a3909a5b9298579c9997aaa31090989709d40751e3599099930965fba52623245cf28b4b128b72207639e6669625e695248239bef945a900eb303665', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115274, 'inotuzumab ozogamicin', 'peginterferon beta-1a', 'Moderate', X'789c6d50cb6dc3300c5de50d106489ced00158898ed948a42b5275bd7d1927a7a22702c4fbbf19d52e2a1e83424c610b3e3808a2c163e161ead8255658ac3c4037d670dcd5764558c2ea2c8c95370a0bfb912271a0d381cd22a142c1482686f8fd21dee43b65443fe738ae7877fed77125cf272bc8ddca43a43e530c1a8c42cefe57ec92b7b459456fa01926bd4f7d2593100769857312f8c5abd4b30e1ad349ca364f70c142d2e6e00bdcfa19705fa5a4397f4d191925c752df1a699ca35d7f016e277a5f', 'DDInter', X'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', 'Synergism', X'789c258c410e02310cc4be32474ebc860f84ed2c0954cd2a4905fb7b8ab8da966f4a84e50bbe437948d9061bcf1927527df6863bb1f9486b0c36bc9563a192551563672c070962e64f5b29bc9481c38ba34c7a3fff672fffacbb3c164e5c78fd0244be2e43', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115411/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c6dcd410e83300c44d1abf80061d1de8045d56655ae60ca80ac3a063981f313755510db2fcd9b68053ec26723d6911bbb057a2f0eddf0150bf4505e30f180c419813a4c725adc39503cb6cf6c4d755e920b27b1ba6b754056ac3fb3fb03e359ebaf4f6a7e2a17714ef01dfe0b4071', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115275, 'inotuzumab ozogamicin', 'perflutren', 'Moderate', X'789c5d8f416a04310c04bfa26302615f910724b01f50ec9eb588c732923c617e1f0d4b2e019d84aabaf501dbfa0ac3a02e532aed524c7d3618c8974f0c171df4f28e4d86c4f94a8d9dbe908061aa052a8552e1e5a069da753c382e44378a06fabc938c801ddc6f746f504348e1decf372aca754fad873d991f89469a98113f30c253c191f6f1e7feefa49dcf6ce2ab47ee886b959003846d43499e47cd7d31b0675313ffbe8a1de93629ab730699b533da2ef9575ef655e58a5173aea09ca957d853e5abd67cbd82a3dd7e01d5847699', 'DDInter', X'789c7590494ec5400c44af524b58903b20f60c121770ba9dc452a7ddb29d8fb83d4ec4027d899dc7572ebf682fba4b500f1cced005836d69471877341952b14b31f5b1b131fcf0c1dd453bbe2436686419b4720f476c1428d4314c9bf6350b8c8f4f480fb61b35f8a647ab98197453a95cb305d79d73cbd927bc37ce00c64b52432fc030f662324b02a52f6a3bc5a99fd1d9cff16ac7ea57be6bdef86768c2aba25210c84e519246733b0556b22abf27f2b270893befe92158fa537c0fc6f37f4f78781b21aefd1199dcdb4de0856f49372da7a2ae46fbf403394e8ae5', 'Synergism', X'789c0dcbd10dc3200c45d155de045da21344ea026e780996c046d8a4eb97df7375df6ea7774db1c40ac22f0cceabad9c34341d5ad0f59c1ea37212b162d042ddf0d3acf0dc0cb96919c82a89530c637a73bb3710c7076ac9f94843545fade04bc8e35a58764278e7be82f1fa0318e7351c', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115412/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115276, 'inotuzumab ozogamicin', 'perphenazine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115413/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115277, 'inotuzumab ozogamicin', 'pexidartinib', 'Major', X'789c6590d16dc44008445b99022c3791129206f01e9725e7056bc1e773f7c14e1459ca2f3033bc79e72eb63a0a393bec8eca0b8585bda448ec03dc1ae34e41f3804a4f8695b2f6ce3788224f85351cd19922679b44c5c22fb9510f519946bc99166b12a481d5f9c8b0a8dcb158a456689ef76b2ae8f3b46cb4ff9d042325e8e28f433fcb33f5a25f6bdf477ce4a671a9a4e2ed3f02c4b1ea436dd30192c6bf005a38a9552d303196249292080348932d2e326c95cf8fafb93f367eb470bc46939f8e192f5ab20dcf36a2933a35d1a3dcf11bd68387f3', 'DDInter', X'789c6d93cd72db300c845f05c77646f5a1bdf4ea532e3e64a67e0158842434fc5148d0b1debe4baa9351da5cec114801bb1f56d745a816a134d12a0f759c4da3dee84d6da1648b645a93493465ef375a64654b961e3a12cf28172a4baaded14d88ef499db8133db3693fb32c6ce2f66e1ffaff7d6be1bb90d73bc64c358ea6299249b13290c6d157a771a6f3afeb40e70b7e309a3dddd46bae378d0339cd32dab172be3c0fc4d1d1cc21f0b7d957e3b07948e15826c90cb35f9e9eae5f075ab3a68c9e18a5f0d787ffc361a0379117189fda4db09a3417a39fbd0c9102e51b7ddf1fdf2f45791885146dd9a5ecb77eeca5d2ae80cb649281ea08a51df0ba51e08db2bc56982326970a50a3e06a07d43034dc0dea22de0d84b1abe4c011d0a1d5691931496305fa1b0c3b6a5821ac34256a5bb3d99e0feb44f544674c196bce12c71e09ec004a5b8322b9861d22078da8c1fd013b24807c579e46b4a0ba6226ba2dc88dc479970b37dd061ac2d57fa93bd1e593281c120697601c5aa23e5b4be74b9dec71f4219087b0babb36636059d08bd05447848bada71dc3b533da481e18ab1dc9fba74045e758fa72cb16564ba134331f7952a923e420170dfb40c81e02a1362e48754b46ca30cf0345c62788ff7b0a08623b9b2078ae3200a867e8c4cb3a2f06aad042af951d3661b472ff0838bf50cd1a716d658f355b4abeecd9fbcd35c2999cfe00da946f6e', 'Synergism', X'789c0dc8d10d80200c05c055de044ee302459eb609a1048ae2f67a9fb72b3107e1271a9765e961d5121e0b8587b2a379b08649292f944dc2c3971d90ebef81a13e4b4622e476cbccdb0746941fc4', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115414/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115278, 'inotuzumab ozogamicin', 'phenolphthalein', 'Moderate', X'789c6d8f616ac3300c85aff24ed0430c7680c12ea03a4a6dea48415292e5f6933bbaf5c7c0602ce1f7bdef4d0fee289d49bcc90de4c8411fb7ee6c9b337446610b6a824e5f146d67c742270a8d35772e61dacf60747507c98426c598721b9561cdef2325d49c26469e559b44c6ec2c61ad6c9d0c6456cfa84ba3fc8e3541b9744406054f385a544cb6dd725429b02653b3f1207c7c62e4d94efd82f7974253f3d8ec4a521296a5fa360dcb7aae7aa7ce8335ea8ef74237617f8c2aed8c2bb3c07855fba53ff541d7613e7e9231eea287fc58ce54862566b5ff74c95d4bfbd379e9fdf44980cae51bb9b198fb', 'DDInter', X'789c35916b8ec3200c84afe203647b96aed40bb8e004b40447c6f475fa0eb42bf12390f137337066cf52bd919bb04ba47bf644d1fa86a3c44e8769d1ba6123f47ba15c5decc6855ad25e22c9432ce42614b87bd64af724959a94f567979803f0189ed0c20fec6ed24e7401cc24e8be4b8d308dda7813e28acf6e3c41ba5207f7eb53d5e92ab00b229838d1f93ff857809f1c6f4812c91501e46f44df0fa74f8e42ec8e8181ceeba8f304ed100325c0e609a9eedfd26122739d056476d710bad9d42299ab358e4258878e3b418e1e1271a3985faf5ca5b5854ade1266218c9f8395a1c5852c747039b2cfa60b6580b75ed8086273b2f4f4b42fa39af9981c96d7f14069213584ad410f39bd018ca8a5c7', 'Synergism', X'789c1d8cd109c3300c0557790ba4b334d00584fd1a0b54b9d87292f12bfa7907774f09a5c7440c4ab0e2d268a8631da99a04bea35bf72381d85f500f8e530cb3f56515bc398a4ea2c80aed8eabd13169efedc3aa25f719ffa72677d2c9f9f8012a912c23', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115415/', '', X'789c4dcec10dc2300c85e155324097e00e08091670db476ac9b52bc741617bd2c281ebf7ac5f3ec98b57db488774371f394c8674a1ac285cd754aa3c29d009b1bc4549c2d14cbb3c90a9c06dfebfb7c673dfae24d690f7d64d3091521c7eae236f6e258ec2b73941a48a951d48f5f781393e7ac2393d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115279, 'inotuzumab ozogamicin', 'pimavanserin', 'Moderate', X'789c5d8fd16dc44008445ba180e46a4924378016ec45b78613b08edc7df059f9c9ef88796ff8921d0fd46017851d4f683883812cf8d3796032c1cb6d986e98620ab6427686ef054493fdc0f180a5b339a7341ce3fc806648bba844faddf991ec605573c08d35a31098a5d23ff67fe67b8a73cc9195011249cac1c0ebcaadfaa8547973c6a8812ef1bc861dc57669736089dcfb997d178ceb724c924b631e48f51fc3cb2ed98d8a49c45a29667ffc02933e66ea', 'DDInter', X'789c55cf416e03310805d0abfc13f412a3aadb56ca05e898b1916c48319e28b72f89d2459720f80f36a332446586538829ecc055069da4935d143789068bc68ee2ab4e44a3c04e8aab5b37add9607c5d201aec2775cc66ab17545676eafd8e6f069d2685cb1b365a4f86b460ef09efb9314c252cb50a7286f36e63b0e602e4c06e9ab50469604d86cc9cf859e28fbccfbc9a35e69fdae87c04d4d5c9f1be7dcca79417bc8c8c3ccc93f1768f3684266e8df5df0309bc7e4be1173b556b59', 'Synergism', X'789c0dc8d10d84400805c0565e0536711598d80027b84b8260585c63f777f3399f203ed57554526938e2c0a5274df221a98e47ab23aa4b82f36e03d5a9b093e3cab0f0f60fc1ba41bd242719468fdb184d5c92cc5e7c0534435978f901427529b0', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115416/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115280, 'inotuzumab ozogamicin', 'pimozide', 'Major', X'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', 'DDInter', X'789c158cd109c3400cc556791374894c10e802e6ece61e2476f0b92d64fa5cfe84405a42f4a073544a311cf1c1c9232eaae1cfea88ea96d0fc6e03d5a5d0c47166ece1db1486f50d7a59fe6407075af898719a3e38b7746593327ddde0532917', 'Synergism', '', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115417/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458b4b0a80300c44afe201bc44d5ad1fbc415ab20834166252a4a7175a3fbb79f3663614b5620cbeef4654bba8469731b672f574d837193043a007160ca4c60da6742a486cf71dd80249334eb1a4f89e1c538643a1c286ece5777312bc013d5b3559', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115281, 'inotuzumab ozogamicin', 'pitolisant', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115418/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c7349ad2829cacf4d2dc9c82f2ac848ccd3517049cc494bcc2d28ca4cc9cc4bd55108ce4fc92ccd55c8afa84c4a2c01f28332734aabf273802ccfbcfc92d4a2e254a01ec7dc4c643d2189401e905d0c0091012307', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115282, 'inotuzumab ozogamicin', 'polyethylene glycol (3350)', 'Moderate', X'789c6d8f616ac3300c85aff24ed0430c7680c12ea03a4a6dea48415292e5f6933bbaf5c7c0602ce1f7bdef4d0fee289d49bcc90de4c8411fb7ee6c9b337446610b6a824e5f146d67c742270a8d35772e61dacf60747507c98426c598721b9561cdef2325d49c26469e559b44c6ec2c61ad6c9d0c6456cfa84ba3fc8e3541b9744406054f385a544cb6dd725429b02653b3f1207c7c62e4d94efd82f7974253f3d8ec4a521296a5fa360dcb7aae7aa7ce8335ea8ef74237617f8c2aed8c2bb3c07855fba53ff541d7613e7e9231eea287fc58ce54862566b5ff74c95d4bfbd379e9fdf44980cae51bb9b198fb', 'DDInter', X'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', 'Synergism', X'789c1d8cd109c3300c0557790ba4b334d00584fd1a0b54b9d87292f12bfa7907774f09a5c7440c4ab0e2d268a8631da99a04bea35bf72381d85f500f8e530cb3f56515bc398a4ea2c80aed8eabd13169efedc3aa25f719ffa72677d2c9f9f8012a912c23', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115419/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115283, 'inotuzumab ozogamicin', 'posaconazole', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115420/', '', X'789c734e2c2ec84f2bcd4bcfccd351f0cd4c4e84b11d730b32f24b528b329333f3149c74143c4b8a1293f3f312abf27352c12ae16cff92d4e25404d72da734b9b224bf38330fc871cccb4c29cd811a0a0071272809', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115284, 'inotuzumab ozogamicin', 'primaquine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115421/', '', X'789c1dcad10d80200c45d155188025d88044176842d126d086da1add5ef0efdcbc97d4f07206c318d274473b5163c8afd23274e239ed509165f81fc9e486e1b29c550e07a616c3e6ad4291677e3e746b2027', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115285, 'inotuzumab ozogamicin', 'probucol', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115422/', '', X'789c4d8e4b0e83300c44af9203e41215a5bbb2a02770901123e158724c049c9ecf862e67e63d699a49672ebe190932c7d06b592a1527478ee1c3594724233fa7b622d3b008a518debcbaa94f9be97a7b3fc8a3356c7852bbb343904eaa030d57f572b53ffcbac095679218be6a7c0069203752', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115286, 'inotuzumab ozogamicin', 'procainamide', 'Major', X'789c5d90416ec4300845afc2b295d2dca1ea6a9695e602c89018d531532053e5f6c593cea60b4b96e1fd07fe68e80e977778e1799d272071bd1d869b104ff0bd4b17929ed79b6941e98fc22b602728277ab93cd9ac29a1e968275d38a43d525c039bb64185a0593da26e520057eee150b0e7d99d13727e336e184c43d8b4af18a21d7481a80c9f57901e6c776c335c2baba5a4606bc7044591b61cd7c34ee647a28226664f53548c87ee2ffb7f266c7880b1ef2df20d904842ee0cbc2c5c921f5b4b2fc6e839a0897f8dc1ee996d52f686297a6e873e3adb9e9f971a3547cafd186e3a646794ef44dcf315a3cebfa67e8fa1', 'DDInter', X'789c35515b6ee3300cbcca1cc0c81d8a7ee56f17d80b3012631195452f45a5754e5fca69017de8319c97de95f2264dba1bb96883de912af58eeb1bd47ef7d72ba8b9905939bc6c92402b37eff8142f502f6cc836d60e2fe448d4b09b566d6b5c30fefe8334677b50452f3a6a8e67beb3d1ad1eb831e8a1923963b4caa177e3c677097a323e8593ece4f1ee0a1dfec9b29693d8a47ff40bde699ce6a9e5701c7152086ddac4d5243c4c1ae3a4dbc66dca4884d41667f160c7e80ce981f83fc4385ff027ba38e3fd989d0ef343facb4167fe98f1b6ddb1713ec5c83d06a687e00e6707f86b670b96c4e8474075fb2de7a49436079dcf189ad2303bb1d17f98ee9419b1769dbd858f910aa823cbf3292d2a5a50a383980d607e5ddc29b09176c14e758f64d3ce0209e275543204d81caf1f5c6634f33939256fc6e465993fde8f2866e7cb3767aac83d', 'Synergism', X'789c358d410ac3300c04bfb22fe81f4a4f3916fa01c5566251470ab29c90dfd7047a5b7660e66594375169e114620a5b902ab586e909f3ff9e269086907bb9a26c92402b6b349c120516851dd9fbda1085028914bb5b355dc7c1787f201aec0755b462bde6817961a7b95e9819749864cee85a79f466565e64e8c9f90e27d929060f83f53859d6728b5ddab73d7e23ba490b', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115423/', '', X'789cf3c94cc94f4ecccc4bd5510801333253804cdfd48acc9cd412b0b053516a49654e66692e5038bf283339b30a280c002cec1433', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115287, 'inotuzumab ozogamicin', 'promazine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115424/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115288, 'inotuzumab ozogamicin', 'propafenone', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115425/', '', X'789cf3c94cc94f4ecccc4bd5510801333253804cdfd48acc9cd412b0b053516a49654e66692e5038bf283339b30a280c002cec1433', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115289, 'inotuzumab ozogamicin', 'protriptyline', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115426/', '', X'789c3d8cc10ac2400c447f656f5e16bfa21705b5a0e839b6290dc4a464a36cf7eba539f436f37833fd8c82dc4830a7eecb5ad1233f0c64e5615d4c3f019ec4d074d42df760bbd861f9a1304c50a3dffd98ce3acba1a4979ae774c5691f9e8a0e606fadd068cce956c98d160789ffc09b7651c33ffb4e3802', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115290, 'inotuzumab ozogamicin', 'quetiapine', 'Moderate', X'789c25cdd10dc3300845d155de04dda55216a03689516d483149d4ed8b9a3ff490ce5d1a3b4326a60d46312dec8a6814f81c1c42bb2863d0178d4e06d52a217914f22a76d22c472707af2b9798104d63bc4429c414974483453650fdd8e60d5316df6a57760cbb5b37ddf2c3782e0904fb491db6fe27eee9baddb9cd693c7e42f8427c', 'DDInter', X'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', 'Synergism', X'789c0dc8e10d83400806d055be095ca2133471015af08e044139cea6dbebfbf95e41bcabeba8a4d270c486734a291dea829f5647549704e76c03d5a9f025c79161e1ed09c17b857a495e64183da6319ab82499fdf111d015cac2cb0de71228d8', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115427/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115291, 'inotuzumab ozogamicin', 'quinidine', 'Major', X'789c5d90416ec4300845afc2b295d2dca1ea6a9695e602c89018d531532053e5f6c593cea60b4b96e1fd07fe68e80e977778e1799d272071bd1d869b104ff0bd4b17929ed79b6941e98fc22b602728277ab93cd9ac29a1e968275d38a43d525c039bb64185a0593da26e520057eee150b0e7d99d13727e336e184c43d8b4af18a21d7481a80c9f57901e6c776c335c2baba5a4606bc7044591b61cd7c34ee647a28226664f53548c87ee2ffb7f266c7880b1ef2df20d904842ee0cbc2c5c921f5b4b2fc6e839a0897f8dc1ee996d52f686297a6e873e3adb9e9f971a3547cafd186e3a646794ef44dcf315a3cebfa67e8fa1', 'DDInter', X'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', 'Synergism', X'789c358d410ac3300c04bfb22fe81f4a4f3916fa01c5566251470ab29c90dfd7047a5b7660e66594375169e114620a5b902ab586e909f3ff9e269086907bb9a26c92402b6b349c120516851dd9fbda1085028914bb5b355dc7c1787f201aec0755b462bde6817961a7b95e9819749864cee85a79f466565e64e8c9f90e27d929060f83f53859d6728b5ddab73d7e23ba490b', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115428/', '', X'789cf3c94cc94f4ecccc4bd5510801333253804cdfd48acc9cd412b0b053516a49654e66692e5038bf283339b30a280c002cec1433', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115292, 'inotuzumab ozogamicin', 'quinine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115429/', '', X'789c258ac10d83300c0057f1005902f5d35f51db05dcc480252786c446657b42fbbbd3dd935be2553007b8a908ce54b01144d16695137b86859ba91cc6d1fbf5b87a2eda4702fcd08a75d79d6280fb81e2550b47c0c829c0508d9a1734fa73265ba806188fca1763e6d2d31b272abaf94f06d31d37d78bc7aab3636109f0729930e9b73f277feb42d3', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115293, 'inotuzumab ozogamicin', 'radium ra 223 dichloride', 'Moderate', X'789c1d8cc10d84300c045bd90a78402788064cec2896488cec8413dd1ff05bcd8c762b82642d59d54ead6384c032766b824aeef603cbe912f1d800358613eba85809f3bc803595c35cf9ed6f14ba04c4ac5d9f516f392cc6f91dbc407296d463fa033dcd2c13', 'DDInter', X'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', 'Synergism', X'789c15ccc10d83400c05d1567e051c4823111d18ecb096581bd95e48f921d779d2bca954ac12d97c1c8c55d0ddb43c84f1f1807c37c9d44bb0ba3d48117e23c779c6bfbb8147a8eda810aafebc706b3504b18e8e8530cf2fb06eedf05096e907c1e32a97', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115430/', '', X'789c458e4b0a80300c44afd203f412a21b174a112f10258b40d34a9a88f4f4822db89bcf639880a2568de1f06e44b5873e39dc185bb80b944e3864855428a1770112a97163e68b2275bde2f917532e0a12fb26d30d49e1331bb09d240d1b146b8ed46f2c59f005999937a4', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115294, 'inotuzumab ozogamicin', 'ranolazine', 'Moderate', X'789c5d8f418e02410845afc201d4bb8cf102a4a02d32d560806ad39e5e5a67350b363ffcf7e08a6a035fa20c0db566060359f0d9796032c1c36d98de31c5146c81ec0c3f37104df60dc7056e9dcd39a5e118fb099a21ada212e9dfce53b28355cd01efac1985c0fce8fed8ff99b0e20ece314756064824291b032f0bb7eaa352e5cd19a30e7489dfe3b0add82e6d0e2c917bdfb3af82716c8e497268cc03a9fe6378d821fba26212b1568ad92f6f947465fb', 'DDInter', X'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', 'Synergism', X'789c1d8bdb0d8030084557b913b8841398b8005ab424150ca59a38bdd5dff318a98598422a9c573b0ed6c409b2c149add023ca9f6cf5a38a9e2ca2f43fb74486456647f2b65744a6c04a8ad3ad98ee1d30a6b97fc17e51195ee25b28ac', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115431/', '', X'789c73cc2928ca2f2e494cc9ccd151f0cc4bc9cf4d2dc9484ccecc03f2924a817269a940666852664a6a7262516a5e7e5eaa8e42506a7a620a905d9c9f0700047117d6', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115295, 'inotuzumab ozogamicin', 'relugolix', 'Moderate', X'789c7d90c16ec43008447f85632bede63f2af552697f00193646754c8471dafcfde224bdf63a9a7933f0a975be3bdb0258c974e60ac4abc9862e5ac1331bae3b24acb09a96700f0dbe1e2035621b96091e99d5d8256129fb0d92222d52a5b99d901ff10c3a508051e02d10e8ff3161c11d8c5b2f1e1a2091b86c0cfc7c728a7c6c0d3d1963630293f60dfa842dd826a9178c22b3bc7b5e04db70964e326ad41a12c789b0ea283b51ad131d87a3e7093efe0ab5de8e61fceb411e0d647dbe4ba59ea236f65ef3cf33a58dd771a5c37cfc0e5634bf168dec5b7b8f359b962df2a399b4c54b861cf411b85cd30b9b9e9655', 'DDInter', X'789c558fd16dc3300c4457b9018a6cd1010a6401c6a26522322990b20b6f5f2af9680be84b7c7c77bc6f8c072baf3202b682b4b8555614ee2e270d31c5d8d8a95f88cd8e5692c742ceebd1da058ae07c05544934c684d16db00ea106977842143d4df915705e584ed10a9b5a143f6ae0a9f69d3986eed62c87d3f275cfcdc17e52bbe1b3f13272780d063dd47ca726e98cbfadcc533fb24c76379f3ed18432fbad9c577ccc1bd13989220b764bc2fc556805bf53f2bc22569df678d1fc1bfe3f4f430a3b97db0f926a7c08', 'Synergism', X'789c158deb0d844008845b990aece5121be05c5c891bd8007ab1fbc3647ecde39bf5607c5979970cd80ed2e6d659d178badc94628a3cd8693e88c3aed1aa8f8d9cf76b8c0714c1a506ea241af996312d595368c0254e886216a9ac80f3c6728b76d88b45f3ab074eb55ffd18a6dbb00a5fca67ad65b2df34963ff2d43f2c', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115432/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c3d8c410ac2500c44af9203e41222b51bad6708fea8819081348a787a5328ee8699f766416a3d6d2d4d84322d729754b760bade2a1565a3ebc9e501b70fd3512bb1119da7b55286c1996609dbdbb3c4df9b1132b01f1e425ac017decbe9e56fddfc28a64b233fc6c7329c', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115296, 'inotuzumab ozogamicin', 'remdesivir', 'Moderate', X'789c4d8fc175c3300c4357c10459a25d8495689b8d4ce68990136f5fb9b9e48af7097c7e8597d88de2c448452ce8ba574d3bace369dc10dcb443567526b809215d71f7783a1830afa328367d0883f1b2623cb1cb39598daeb422ad9d932b5d654ecc18ddf27e6d353b66b7f9efe8e70ddf42c1d2639fc9a1495b85162eed5f4dbca234f3ab0fc9514d1339d675926faf0ff36bff67de644631a1d6f72f1f96d065d1c2bcfd01a8b661c1', 'DDInter', X'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', 'Synergism', X'789c0dcc810dc3200c04c0557e80aadb64002738c52af8236c42c76f6e80db3cada17328cc4f8e2e697458406eb1267bd3170efac16e299e98a1e089a1bd68d86d03cbb2e2eb5c8eaa9724933f3b50c6fc04a272b6825d9f8f56b46055755c8cb0e77eff0133f73053', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115433/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c3dcd410ac3300c04c0aff801fe44e8a1170702293de4b6b59520b0ad2052bf3faa4373db153b28a070fb26aee4dd04e503bb5263f5ee9929dee5455556b1e890b15235954c8c50d851a27743b16d455fcf5ce82fdf0622c72cbd2df8d11e1ff8c8419b5e2498b577571945e90408623844', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115297, 'inotuzumab ozogamicin', 'ribociclib', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115434/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115298, 'inotuzumab ozogamicin', 'rilonacept', 'Moderate', X'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', 'DDInter', X'789c758ed16d03310c4357d1006980ee920ea0f3d1b010db3a4872d2dbbe0a907ee697787ce4ad819c2be2249e3ba156295c4ed24a3203d6b1ee32bfbe69eb5aee30cf98648c35d5d77118dcb1d3c12198e1d4f8019a1ab40193e0c15b176fd8aff433433a0d35a4a2aa8dec68ba9cf8c1d213c4e5d3a6375d3d670c1596e4f9de20de874cf12ce58bd0cfcf2ea446d170febbb2fc628ac996d853a2117ec3304085d7ebdaf50f297e6ab0', 'Synergism', X'789c0dc8d10dc3200c05c055de02a9945db2808187b0420cc2a652b66feff3ae46b854c60bb102d6aa59f28b51a1165c9dfb563b4ea43ef2cde5ff863ecfb6e17bce4577164c09a585a3c997b01148a4811e92ba7a63f9fc0013fd2754', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115435/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115299, 'inotuzumab ozogamicin', 'ritodrine', 'Moderate', X'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', 'DDInter', X'789c358fd14d04310c445b990296fba0051a0089067c896f63918d23c739b8ab1e671192bfec7933e3379a2eda2003c6498f835be60cb9e1ca4e2fafa05d9b0c1f2063ccb16e0d21bc4aa393fc162f502f6cc836f7012fe448d4d04dabb63d168c8fcfe09ced4ef582f720b985e7283a6b8e2850becb3277c560fe5aecd11d0767495441ee019c456fcbef01fee96ce19218e311523dfe934f4b690b743ec335a569766a3570b5419911d375958a1e3315d04096e7531a8fb1a1ca5e820d61fe5bdc28b4d2f60d9d6a173fbfdf2061bccf4a86109bc3cac3cbb1add7cc17b922afc6e465835a946d493b5f7e01be668bbe', 'Synergism', X'789c1d8bdb0d83300c4557b90bd00f5660824a5dc01037b10436b21dba7e03bfe7b1504f3185049c373b0ed6c205f2c5ca49d30caaa612192067f4b89d6284ab283de74fb2c1b2b1a378af816c94d84871baeda67500c6fb33be64bf687ffd01af652a58', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115436/', '', X'789c732a4acd4dcd49cccb2fc94c49d55170cbc94c4acc2b4e2dcaccd351704e4c4a2d4acfcfc9cc03ca3815e5e7e6271765169480b97e890545f915a940559e49a540665a6a1e001f5a1bd2', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115300, 'inotuzumab ozogamicin', 'rivastigmine', 'Moderate', X'789c4d8f416ec3500844af329b4aad5465d17537ed0d2af50218e37c941f88e0c78e6f5f9c5525102c18e6cd17cbd83b37ef6a92438252a0d674d2e191b8d28e46ab60a5b30f3765c8b2088f841b4613a49ad308a50eb219c7eaab580dbe770a98cf92efd89a72833353aa1bf5bed76fd3a54c41892968de99625682079a500c4cddf982d7cf8f97b713be85e95e70ff2f354108cd0b16e2e2c5527d70d32ca8bab9da38dce940f590a15c9c4f853c342bc5d6c4c07e9d2aff8c4d47039d0b3f4b4103b7f0ee767e26fdf9c5f12e56eaa73f5ab7734a', 'DDInter', X'789c358fd16dc3300c4457b9018c2cd10512a00bd0126d11514483a29d3ad39772d12f41c77bc4e317ed2eda201d940fe99cf12edc4089fdaca96895c6ddd9a833a41599c5d5a26c8cfd6a8b1764dbd70e2fe448d4b099566d6b048cc77760c11f546fb8930b37efe845f79a31335edac6c6d8b4a86136ca6722cb4213c84df488be49da2bc5b46a7a825a463f5bd28da7ebf32fee8acefcc48bb324aac17bc0d775cb7039c13f1b5b18244696cf679cd62754594b8c2973fe0b160a6569eb343ccd47085d428ec9cb84f0ec55dfe315335e2fb7e0cde728dc7e0155677e99', 'Synergism', X'789c1dcbd109c3300c45d155de045d221314b280628b4860a422c909dd3e26bf9773379aa56ed004f54b933b6e610335aeff68e2438db33828196aa28796c7c2c198afd612f49867a2840a8d0cbff0e176aec0f8ee6b5bff45e3f300e4cc28df', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115437/', '', X'789cf34dcd4dcc2bc9cc4bd55170cfcccb4ecf5748caccc94f4ad451704c294d4ecc2bcd4d4c0200f0890d10', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115301, 'inotuzumab ozogamicin', 'roflumilast', 'Moderate', X'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', 'DDInter', X'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', 'Synergism', X'789c158e41b2c3300843afa26517f9ff0e3d8aeb909a191b3c80dbb4a72fd949e28dd0bd56b59de5895044234cd37dd5402f0fea577ea8c1f4e86b702f1e6081eb20545d12c6e4d8524bd5c15124b09cf0e668e03196a8af398ddcf945284f9270f8aa0dc531289a86d1598236946f89c63a8d251dcbd1f9e4511e1b287bc92acd484a76f8c78306d77c6bc155d399f2eeb8d179517837926b47a22d91bfbc8facf9ff01ad01593b', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115438/', '', X'789c4d8ddb098030144357e9005dc2c76f11c405ae1269b12fae2da8d32b15ac9f39e424934688fab4d678483138b2e6ca8e6629265c88b06f50e085620a31732936cef89fd7c273353b5a57143e62ffa80a3e3d731bed498afefc9d1e894d8d2a306e81c037c2', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115302, 'inotuzumab ozogamicin', 'romidepsin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115439/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c2d8d510a02310c44afd203f4120a7ef8212ce80562772c81b659d254969ede14fc9979300f6683da98a3d23b86aba8614a65e71777ca6805a9602494182e959b147c47e1c62950e2dd359aa830e946e64a3185918b5853563ae533fa11c3864cfd20f5f4e97ed2ffe629264a7de1ad79ef688b1fa2f8016b8f38da', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115303, 'inotuzumab ozogamicin', 'rucaparib', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115440/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c2d8d510a02310c44afd203f4120a7ef8212ce80562772c81b659d254969ede14fc9979300f6683da98a3d23b86aba8614a65e71777ca6805a9602494182e959b147c47e1c62950e2dd359aa830e946e64a3185918b5853563ae533fa11c3864cfd20f5f4e97ed2ffe629264a7de1ad79ef688b1fa2f8016b8f38da', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115304, 'inotuzumab ozogamicin', 'salmeterol', 'Moderate', X'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', 'DDInter', X'789c358fd14d04310c445b990296fba0051a0089067c896f63918d23c739b8ab1e671192bfec7933e3379a2eda2003c6498f835be60cb9e1ca4e2fafa05d9b0c1f2063ccb16e0d21bc4aa393fc162f502f6cc836f7012fe448d4d04dabb63d168c8fcfe09ced4ef582f720b985e7283a6b8e2850becb3277c560fe5aecd11d0767495441ee019c456fcbef01fee96ce19218e311523dfe934f4b690b743ec335a569766a3570b5419911d375958a1e3315d04096e7531a8fb1a1ca5e820d61fe5bdc28b4d2f60d9d6a173fbfdf2061bccf4a86109bc3cac3cbb1add7cc17b922afc6e465835a946d493b5f7e01be668bbe', 'Synergism', X'789c1d8bdb0d83300c4557b90bd00f5660824a5dc01037b10436b21dba7e03bfe7b1504f3185049c373b0ed6c205f2c5ca49d30caaa612192067f4b89d6284ab283de74fb2c1b2b1a378af816c94d84871baeda67500c6fb33be64bf687ffd01af652a58', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115441/', '', X'789c4d8e410ec2300c04bf9207e4131401e2d01b3c20725cba52125b2639f4f7241455dc6ccd6a34b364aee12d85ddd24c4265ef9e992921a2a065efa616b973c44e6e6923d1cd4c7676fadbcd87c9bb8ba2b0ae86f15c53aba01f399b64792510c80542f4eeae16aa897e250fc8714fbd6238d73d2f420791d21b3f3b304423', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115305, 'inotuzumab ozogamicin', 'samarium (153sm) lexidronam', 'Major', X'789c1dced10dc2300c84e1556e022484d884054c7a25919a38b25da0db63fa7afaf4eb1e956a8c566443d15168c3c16ff340540994caae516932b92783bc38c22163c1b9e3a983e862a61f2c9c4677f98b2e07a646ea26c1aca53ab8a9eff344ed4d705d59d2ea0a976cb4bdc33baef71bb63cb1980ee9971f4e463e39', 'DDInter', X'789c7d924b8edc300c44afc203180d04414e9075802c7201b6455bc448a28792badb73fa94e4992cb3e98f44aaaa1ef9270a652e7de3b575172797d57296122af1c33468d969b582436d5c1af52a641b55ceecda33d54cdf7e7ca7242f0d6e85333db5455aa3646b519c8f93cc495e4dbc70a2bba0c4392837b5425f25bd24a915b745366dd07621c8e9aa073709d48cacb7a7e81e470fb9d6b77aa35fe6620ff1e57f866ab49e02156b789f767d4821dee0874487fec8836f046b2edc101e063ac4d3b4271479384357d32cb4210e0779ef300676eef69cd460e3bcd14fee331897406b323c9aad68331f202174b7f2af6beb65bd8a47daf0d0caf724a41b8873c85ab436bf384da81328e55392357be94abc4faf5a61e0bdab4bb8d16f34ccd3cfd8f7cfa72f881865c3a84730753ae2598198cbd0c4d149411e78fda0aa7ba933443df3d12cd7617e4ad77e1c8e610d5bb5af9140e7e0940c5308faf1a105970b6df0b17759308916d9f7731c29a8967d01dd5efbd8862432570c4cefdeb5ce5bfcb9f421a965930bd297d62673e06bd494ea9004cc288c15c03220851bb78572af2b583216114560e16df89a2318538e0bc4cd02048021c99e179aebd50811d10298c308f41367fcae6f5ad063e19c42a818740e449ae6bb979123f439e8f1390777fb0bdd56402a', 'Synergism', X'789c358d410ec2300c04bfb22f4042889ff00193b88d456d578e43cbef0907aebb339a476328d958a8e4080e04175765ab1df476a9622b8adb1c25c912a3337c4127a590a1e88aebfd868d4fa9e1468a43b2a13456cfc641fb071ee033398c363c7922415528c50d7f64d8c6bdcfd778919ced60cc9c14d929b9221d3ef26059dbcf41487ff5cb17ba7a4781', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115442/', '', X'789c458ccb09803010445b490136217af1e007b18151f6b09044d96c44ac5ec90adedecc3c6622d17ce780b5720d69beb8e0e82150abeb93bcd122489fed282862e248959b10f975cde90ef6fcf140db3fb47b5288b7ff3af089a8286146c81b8b69fd2ef4001fd536b5', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115306, 'inotuzumab ozogamicin', 'saquinavir', 'Major', X'789c5d8f516e03310805afc201d2dca56a2e400c1ba3784d0a78abbd7d715691a27c027e33cf3ff83ba4e32606d2a1e87acd29443bfc495430093dae2bee50703803a9f39771c360828769d37e3b22ba405486ef4bb2826dc376864b65350e29d8da7e4a03d22a5d3cec4da31933c01bf7f04460a4aabfd89fcc6715631f2d66672492908d8197854be6b153ee8b317a1634f1fb2cb625dba48c862932ab7bd455d0e7cb3648a646cd91f27f0c0f9db203e583887b6e31eaf91fb73871a4', 'DDInter', X'789c1d8dc10dc2400c045bd906a0092a40a201733e722b2576623ba17d4efc46f39879b8e846635648d10dfe41b0dce462dcdeee595d91729cfc2b7c59035ea30734ce2551430a4d0c7bf8eab64cd1f17c81563d2e59c144734b6a8f999a385734659399beff0096de3114', 'Synergism', '', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115443/', '', X'789c3dcd410ac3300c04c0aff801fe44e8a1170702293de4b6b59520b0ad2052bf3faa4373db153b28a070fb26aee4dd04e503bb5263f5ee9929dee5455556b1e890b15235954c8c50d851a27743b16d455fcf5ce82fdf0622c72cbd2df8d11e1ff8c8419b5e2498b577571945e90408623844', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115307, 'inotuzumab ozogamicin', 'sargramostim', 'Moderate', X'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', 'DDInter', X'789c458fd10dc330084457b901aa7e549da09b109bc4480e588634caf6255ffde4eee01e1f2e7438c35644630c0bd610ea70569790afc4759b9386d47ea1a6524537ec1777938ac2bd3bc250480b4f94c6bbe5a95cb81ec881c2860987146cd3ce6858a9844d87373b7a855a60612445c529d144f17a23bd8c2cbcda4cbaf997688daca1ba8b8ac7a410d39b90925bd94627bfbb68cb47fcf903ecaa53ac', 'Antagonism', '', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115444/', '', X'789c6dcd410e83300c44d1abf80061d1de8045d56655ae60ca80ac3a063981f313755510db2fcd9b68053ec26723d6911bbb057a2f0eddf0150bf4505e30f180c419813a4c725adc39503cb6cf6c4d755e920b27b1ba6b754056ac3fb3fb03e359ebaf4f6a7e2a17714ef01dfe0b4071', X'789c0b482d2a29ad2acd4d4cd251704e2d29adc80433fd73128b124b20c28e65a93910966b4e3e5c714851623194a3909a5b9298579c9997aaa31090989709d40751e3599099930965fba52623245cf28b4b128b72207639e6669625e695248239bef945a900eb303665', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115308, 'inotuzumab ozogamicin', 'pfizer-biontech covid-19 vaccine', 'Moderate', X'789c5d514172c33008fc0a0f48f399f60358221613093c0239e3df1739993693932476975dd04f21c0dc58d8bca3b30ae80d583039efe8942f70e75ae7a91dd40bf5071b81a8b0dc28583a0c764c89850c5c815b1ba236b6ad931965d8a22d891bb0c14a421d6b3dc0f046b00c8786072c11c24c134f4778b01740c87cc62a51096b1b8b6ece0debcba1eaca09c26353894079d07447715e341f3142e185e74057f81ea9fcc798862ca98e1c8aa2a17d1485823b45b7149448372fbc3f9db1d3ebcdb27e8c171cc075b6bd9cd6f5685bd17438c15a7519956522f57ed4b00ff93bb991e3a2959da2d031f3b9ff0b98363a09bdd068514c7fb2c26b81ac166f9b1f95b407ace6d495b39d717327d117e05db73779c05565fd0a7a8b6d0514eb8c622c0be38f3fdb5d7f0104abcdbb', 'DDInter', X'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', 'Antagonism', X'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115445/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115309, 'inotuzumab ozogamicin', 'selpercatinib', 'Major', X'789c5d8fc16d034108455ba180c4bd44710364603d28b3b00266a3ed3e8ce3532438f081f7e193c7c1de3045e50b1a6ae50c8666da58d3ab61fa4e7cb052d570b80dd3c75306db203bc3c71d4493fdc471837b67734e6938c6f5561ca4bdd8f142c18f6407ab35077c14310a81f9747eb1ff3361c70b9c638e2c0d9048524e06de366eb58f4aa537670c267089ef75d8b9ae97360796917bbfb2ef82b126c7245936e681c45071d832fb43c5a4fab454cc7efb05e9ad6bcf', 'DDInter', X'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', 'Synergism', X'789c1d8bdb0d8030084557b913b8841398b800b668492a184a757dabbfe731530f31853438273b4fd6cc19b2a371bdd81385a86c9fefed138a516da2f46f8f4481456147f67e3444a14022c5e5564d8f0118cb3abe60bfa94e2f665229de', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115446/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115310, 'inotuzumab ozogamicin', 'sertraline', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115447/', '', X'789c3d8cc10ac2400c447f656f5e16bfa21705b5a0e839b6290dc4a464a36cf7eba539f436f37833fd8c82dc4830a7eecb5ad1233f0c64e5615d4c3f019ec4d074d42df760bbd861f9a1304c50a3dffd98ce3acba1a4979ae774c5691f9e8a0e606fadd068cce956c98d160789ffc09b7651c33ffb4e3802', X'789c458c4b0a80300c44afe201bc849fadda2ba4258b40d3424c8af4f482adba9b37bc1987a2568dc18fc3826a173d712a185be920911a37383c25fbfc190b04eab063f8bd359f0a12fb175381a4d040b1e6f88e1cb2971fb72c78033d8c3564', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115311, 'inotuzumab ozogamicin', 'sevoflurane', 'Moderate', X'789c5d8ed10d024108445ba100632f461b200be712f7c0007be6ba97d3f863c2d764e63daebcd932a6a332acb843c3190c4fb7617ac71453b005b2335c6e209aec1b8e33dc3a9b734ac331f61334435a4525d2bf9b976407ab9903de59330a815974fdb1ff991fbb73cc9195011249cac6c0cbc2adf6a8547973c6600297781c8f6dc57669736089dcfb9e7d158ca33926c9a1310f2486baa71db22f2a26116ba598fdfc06137e61ae', 'DDInter', X'789c1d8dc10dc3300c0357e1afbf2cd1090a6401c5566203b61448728a6c5fa7df238f7cd388aa82ea304eda3b4be68cbac3f9d2bd0d23e1271dfe60c1ec6c55e82f7d6b14681436641b87230a0512094ed3a6724cc0f8acd30bb68bda82758273da2cf1f259b55cf5224fa391c183623848f27cb7d1c18d53cca93bd8e14547cbd818a9a973bbd1556aa8715e7ef2b94a78', 'Synergism', X'789c1d8bdb0d8030084557b913b8841398b8005ab4242d184a757dabbfe731530f31853438ef562b6be20439d0f8b6a37427e5cff6f661c5683651faa74722c322b323793f1b22536027c5e5564ccf0118cb3abe60bfa94c2f13732923', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115448/', '', X'789c458c410a80201045afe201ba4450410b5b5417301c71c09cd011f4f6a98bdabd0fffbdd3223de059b9418cce34f25879871bffb546322e05e5611007694cb7a05c2ec5754b604b1632f6c6d29d526982f8391b72a014ab84ba25d29f9efdf79214e005f992348d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115312, 'inotuzumab ozogamicin', 'siponimod', 'Major', X'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', 'DDInter', X'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', 'Synergism', X'789c0dcbd10d80200c45d155de04ee6274814a1b68a22d2985f9e5f7e6dc4bbb9b7ece6834609e78440c2327ab30d4d029552c07428ae852abe09875201b250a6d11fefaced904e7bd9f9458f41e3f3bdc2209', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115449/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115313, 'inotuzumab ozogamicin', 'sipuleucel-t', 'Moderate', X'789c7d90416e03210c45afe2652b25d39b74935e80c067c62ad80843abb97d3ca32c9a4d37966cacf71ffe048f0d9dbc50c1fc0ecd3b181bb5ae116976906827e336fd3da25cbf680b3fa03b2064632646a2ec2bd3402c14b5de59c26015fa7538c50d558f90d076f23dae758ada6ccd838c1d1556c8307ac3b22e17b2dd062a4727f5c151bdebcac9de17bab144bcbab86972df55dc62a80b719d250c9c3f3aa3f0245e1c2871f6ee61a7ac66aa3b8a5effb5aa61a750c6f346c89963883e92f471dc25648cfd40fdb55a1e97c78038', 'DDInter', X'789c1d8ed90d02410c435b4903500b1f3410660c13692ee5d815dd93e5d7f67bf2835d30ddc8da8a5ee9052aac7847ef5fc2c13dd851c917553874c8049d0ddea0244e623450a5f035e7bd756d95242e4051a3809652152b6bbacc487bc35817cefb7b753246cc65912ccce400f1e77f284559a7c715ec23333ac51b99ece84873bf3def3f4ec84900', 'Others', '', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115450/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', X'789c6dcd410e83300c44d1abf80061d1de8045d56655ae60ca80ac3a063981f313755510db2fcd9b68053ec26723d6911bbb057a2f0eddf0150bf4505e30f180c419813a4c725adc39503cb6cf6c4d755e920b27b1ba6b754056ac3fb3fb03e359ebaf4f6a7e2a17714ef01dfe0b4071', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115314, 'inotuzumab ozogamicin', 'smallpox (vaccinia) vaccine, live', 'Major', X'789c5d514172033108fb0a0f48f3961efa01629398890d3bc0a6dddf17ef269db637b04048f24723c03a58d8c3305805f40a9d1f043eb0f745bfe0c1b63a3cb0141682ba1acb0d788c55d4d7653172470950039620f16494c8515d3a7a70816864b86c3070834ba2ee5a18832a7c72344030f6fbbc5bd99d52cc8eb15ca9ec8aea4a100a240da52462b4742e3f6a5fca0e9d2cf31e4c5994d307ed6eb04dd2299ba0e85828267e86f72422097fc9fbeb6cee5c27e3060d3315a392c37ddb8b8ca94edf68f4ec6734d8ef5b4fd259de26f3690f6450e0453b07e58361e5ddc0095cc79198355a07cec05e6b8d6f0daa7af63e8d14b584d5834cb9fa7eba1a893e81305d7ead27dc556e6f393e32c084b01fdfd4b0a7f27f74e76f4521c688', 'DDInter', X'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', 'Others', X'789c2dc9c109c3400c44d15654404831e940c8832df08e16496be2eee3434e1fdeffc46a275ec220067207ed961a7a9e33be72a99953db83e22516ec54e7e6a68d4d9c329f097649c2e09773171f63316acd99a8f20bd20752e72d91624ac3930323fefcfe017ff5339e', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115451/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115315, 'inotuzumab ozogamicin', 'sodium phosphate, monobasic (p32)', 'Moderate', X'789c1d8bc10d02310c045bd906e0018df0a001136f944897388a1dd0754fe0b79a997d1622594fd66a480f2c272ce3659d6832a77da01c93eedb3aa42bdcb4ae8651cc4791201e97fb6dc7278abc0951ad51f768270ff335feef1f60ce4ce1d72fd8a92b4f', 'DDInter', X'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', 'Synergism', X'789c15ccd10d83300c45d155de02e5a35d841542e3124b8d5f643ba5e303bff748772da9621988c6f9add8049da649978a0f1df27f4b84fe041bedc2e2ce0331c7f0bbd350a7abed489792fd7ae1d06c08569d1da331462b29581fafe77202504229d3', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115452/', '', X'789c458ccb09803010445b490136217af1e007b18151f6b09044d96c44ac5ec90adedecc3c6622d17ce780b5720d69beb8e0e82150abeb93bcd122489fed282862e248959b10f975cde90ef6fcf140db3fb47b5288b7ff3af089a8286146c81b8b69fd2ef4001fd536b5', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115316, 'inotuzumab ozogamicin', 'solifenacin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115453/', '', X'789c558e4b0ac3300c44afa203f812a1a1bbd22eb2e952716c2c90a5e04fb06f1f275d75373cde0c336322ef042d8981053764f4c406a61855a846b08135d1e60c7c35505c49467cb7bed6d2e52acd145d099d2157f6da6ef5e3a46846815db95f1ccba00f64fb3fb924cdfb40069e8c87b65b9b0e94df8997267702b6e93af2', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115317, 'inotuzumab ozogamicin', 'sorafenib', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115454/', '', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115318, 'inotuzumab ozogamicin', 'sotalol', 'Major', X'789c5d90416ec4300845afc2b295d2dca1ea6a9695e602c89018d531532053e5f6c593cea60b4b96e1fd07fe68e80e977778e1799d272071bd1d869b104ff0bd4b17929ed79b6941e98fc22b602728277ab93cd9ac29a1e968275d38a43d525c039bb64185a0593da26e520057eee150b0e7d99d13727e336e184c43d8b4af18a21d7481a80c9f57901e6c776c335c2baba5a4606bc7044591b61cd7c34ee647a28226664f53548c87ee2ffb7f266c7880b1ef2df20d904842ee0cbc2c5c921f5b4b2fc6e839a0897f8dc1ee996d52f686297a6e873e3adb9e9f971a3547cafd186e3a646794ef44dcf315a3cebfa67e8fa1', 'DDInter', X'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', 'Synergism', X'789c358d410ac3300c04bfb22fe81f4a4f3916fa01c5566251470ab29c90dfd7047a5b7660e66594375169e114620a5b902ab586e909f3ff9e269086907bb9a26c92402b6b349c120516851dd9fbda1085028914bb5b355dc7c1787f201aec0755b462bde6817961a7b95e9819749864cee85a79f466565e64e8c9f90e27d929060f83f53859d6728b5ddab73d7e23ba490b', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115455/', '', X'789c734c4e4d2a2dc9cfc9cfd151f0494c4a2d490433fd125320620145f905458979108e6f6a099007613b271695a5a66482d9aec5b9104127a0fe0a08d32f3529b30c6a466a1edc0ea7cc62b811bef945a900b5632e7d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115319, 'inotuzumab ozogamicin', 'sparfloxacin', 'Major', X'789c658fc16d034108455ba100c7bd44710368603d28b3b002669ded3e8cac9c72435ff0dee7eb40df86fd6013851d2f683883812cf8c3796032c1e1364c9f98620ab6417686cf078826fb89a30608db198eda60cdb8c3a3b339a7341ce3ba4133a45d5422fd0d794976b0e238e0739d1413b3dcfa27fb2759dd9c638e5c3e2492949381b78d5bdda352e5cd19a31abbc4f76a7a16dba5cd812572ef57f65d30d6e698244b631e48f570d5b7257ba36212b1568ad9efbf95ce6d3a', 'DDInter', X'789c15ccdb0dc3400844d156a68234910a2ca501b460ef481bb0803cca8ff377753eee3d449f7456a734c3113bea94dc577c65d0f1614f444f4b68be8e424f690c719c192bfcb8c0b03d406fcbb72cb030c28b6a69facf6b4d570e69d3db0f972e2ac0', 'Synergism', '', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115456/', '', X'789c73cdcbaf484cceccd351f04bccc94cc9acc84c5600f25374149c33e1522145f96589693930ae4b6a0e9c0700ee881772', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115320, 'inotuzumab ozogamicin', 'strontium chloride sr-89', 'Moderate', X'789c1d8bc10d02310c045bd906e00d7dd080891dc5d2c53ed90ee8bae78edf6a66f63504cdadf9d4222bac1478c7db4d3029c2bf60d943324f9b206364855be99ab7c7136d6c1eca577c60d04740cc5a7a8e79c8e6b9f6fffb02d2bbb4cafb0fede52bcd', 'DDInter', X'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', 'Synergism', X'789c15ccd10d83300c45d155de02ed37dd82150271892562a367a7303ef4f71ee9ce25552c03d17cec158ba0bb693aa5e2eb845cab44e84fb0b83d58483f11e338f8ef6ea8836a1b9252b23f2f9c9a0d91744b1dfd357db0b6dda955de3750542a51', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115457/', '', X'789c458ccb09803010445b490136217af1e007b18151f6b09044d96c44ac5ec90adedecc3c6622d17ce780b5720d69beb8e0e82150abeb93bcd122489fed282862e248959b10f975cde90ef6fcf140db3fb47b5288b7ff3af089a8286146c81b8b69fd2ef4001fd536b5', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115321, 'inotuzumab ozogamicin', 'sunitinib', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115458/', '', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', X'789c458ccd0980300c855771009710bdaac50dd29243a0692126453abdd08abdbdeffd3914b56a0c7e9e56547ba8c9a560eca683446adce1f494ecef1f1846b4e55b41e237672a90141a5cc016487a6d51ac39d2f7e090bd0cdcb3e00b41323573', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115322, 'inotuzumab ozogamicin', 'tacrine', 'Moderate', X'789c4d8f416ec3500844af329b4aad5465d17537ed0d2af50218e37c941f88e0c78e6f5f9c5525102c18e6cd17cbd83b37ef6a92438252a0d674d2e191b8d28e46ab60a5b30f3765c8b2088f841b4613a49ad308a50eb219c7eaab580dbe770a98cf92efd89a72833353aa1bf5bed76fd3a54c41892968de99625682079a500c4cddf982d7cf8f97b713be85e95e70ff2f354108cd0b16e2e2c5527d70d32ca8bab9da38dce940f590a15c9c4f853c342bc5d6c4c07e9d2aff8c4d47039d0b3f4b4103b7f0ee767e26fdf9c5f12e56eaa73f5ab7734a', 'DDInter', X'789c358fd16dc3300c4457b9018c2cd10512a00bd0126d11514483a29d3ad39772d12f41c77bc4e317ed2eda201d940fe99cf12edc4089fdaca96895c6ddd9a833a41599c5d5a26c8cfd6a8b1764dbd70e2fe448d4b099566d6b048cc77760c11f546fb8930b37efe845f79a31335edac6c6d8b4a86136ca6722cb4213c84df488be49da2bc5b46a7a825a463f5bd28da7ebf32fee8acefcc48bb324aac17bc0d775cb7039c13f1b5b18244696cf679cd62754594b8c2973fe0b160a6569eb343ccd47085d428ec9cb84f0ec55dfe315335e2fb7e0cde728dc7e0155677e99', 'Synergism', X'789c1dcbd109c3300c45d155de045d221314b280628b4860a422c909dd3e26bf9773379aa56ed004f54b933b6e610335aeff68e2438db33828196aa28796c7c2c198afd612f49867a2840a8d0cbff0e176aec0f8ee6b5bff45e3f300e4cc28df', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115459/', '', X'789cf34dcd4dcc2bc9cc4bd55170cfcccb4ecf5748caccc94f4ad451704c294d4ecc2bcd4d4c0200f0890d10', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115323, 'inotuzumab ozogamicin', 'tacrolimus', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115460/', '', X'789c3d8dcb0d02310c055b71016902b1027158891682e32c961c1be58336548f9703d7d17b332babed9c58022c64fbc4a7092344e414e01c057914d864a069ec14608d9b523b601b927fe82a13ed356b35751ee0ce85b0baa68c16e054bcf020fdd85f7b618dad53e5e4efdb9baaef3bebd1cb99589d2e8c629934a227add217366e3d03', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115324, 'inotuzumab ozogamicin', 'talimogene laherparepvec', 'Major', X'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', 'DDInter', X'789c758f416e04210c04bfd2b7dcf635fb01077a164b60103613cdefc328c9de72b270a3eaf253aab6fea211550ae790c97132c14b5f35c37ae09358ce0c350c09a5856332514fb517b4b565ddd71893ee7a12b139322ef4892496b84761ebbfeb079e93126d63f0a55110ff2934b960dcc5d16f87cc8373eee7b2d00a3962937da5f22e5447564f7de7b6f647b17c677fd61ffe234bf8e5c18622be01c7a1e98eeb755fd54fee8ec7377e006a23', 'Synergism', X'789c2dccc10903310c44d156a68254930614efb016d892906c43bacf1e72faf00eff2d43a7df346248678624e3b0a1baef71c17ce143ece20535842ca5ad42b2518fda0d9d739bd78e4856e921d6f391f8c2134dacf149e7f43fbf7efdc02c3a', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115461/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', X'789c2d8d510a02310c44afd203f4120a7ef8212ce80562772c81b659d254969ede14fc9979300f6683da98a3d23b86aba8614a65e71777ca6805a9602494182e959b147c47e1c62950e2dd359aa830e946e64a3185918b5853563ae533fa11c3864cfd20f5f4e97ed2ffe629264a7de1ad79ef688b1fa2f8016b8f38da', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115325, 'inotuzumab ozogamicin', 'telavancin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115462/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c3d8c510ac2400c44af9203e41445fcb22a28fe8736c5c06eb2acb1747b7a63a1fd19667833f3149591564b8c7011e5703222743488d71045b855719a49b770b7d4725b44a143385171cb6d03af28ecbe677fb3528e3f8447e1c14577768d5f9bbe95d4ed9fcff6998e9d55fe011c77353c', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115326, 'inotuzumab ozogamicin', 'telithromycin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115463/', '', X'789c73c92cca2cc928cacfad4cceccd351f0c9cc4b86b1438af2735213f352607ce79cccbc944430070036711492', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115327, 'inotuzumab ozogamicin', 'terbutaline', 'Moderate', X'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', 'DDInter', X'789c358fd14d04310c445b990296fba0051a0089067c896f63918d23c739b8ab1e671192bfec7933e3379a2eda2003c6498f835be60cb9e1ca4e2fafa05d9b0c1f2063ccb16e0d21bc4aa393fc162f502f6cc836f7012fe448d4d04dabb63d168c8fcfe09ced4ef582f720b985e7283a6b8e2850becb3277c560fe5aecd11d0767495441ee019c456fcbef01fee96ce19218e311523dfe934f4b690b743ec335a569766a3570b5419911d375958a1e3315d04096e7531a8fb1a1ca5e820d61fe5bdc28b4d2f60d9d6a173fbfdf2061bccf4a86109bc3cac3cbb1add7cc17b922afc6e465835a946d493b5f7e01be668bbe', 'Synergism', X'789c1d8bdb0d83300c4557b90bd00f5660824a5dc01037b10436b21dba7e03bfe7b1504f3185049c373b0ed6c205f2c5ca49d30caaa612192067f4b89d6284ab283de74fb2c1b2b1a378af816c94d84871baeda67500c6fb33be64bf687ffd01af652a58', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115464/', '', X'789c4dcd410a02310c85e1abe400bd84ca282e5c7a809244e741db84d82ee6f6166640b7f9c2ff165f55024d133dac6acf1f6b4aaf1196fbbc3dab7281a061d444e7213a1d32e5563636df226cb7d3dfdfaf9468f119f7759fb896d1c1875cc2aabd0b184c992189ee1eb987f91109fd022b1e3a37', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115328, 'inotuzumab ozogamicin', 'terfenadine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115465/', '', X'789c4dcdd10980300c04d0551cc02544ffd43f17d07a62204d4a2c623bbd2056fc7cdc71d7236aa40d52572342b2d993a0ae069cea10c9283f6e775673c971f12f6b9cd1391ff1c164144c99d64f6088bcb34d069766876b31f5618750b96d19bee4a31a6e566d3adb', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115329, 'inotuzumab ozogamicin', 'teriflunomide', 'Major', X'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', 'DDInter', X'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', 'Synergism', X'789c4dcd510e02210c84e1abcc018c97f0240466972640372da0de5ef0455fff69be3e8a3a51b549579376421cc6a8b5b22526c881c2a38ca65512a1864e935f58e7c3f75dc315bab075c7332b82117198ad50de5ba4cccd2f2087c96ff99b96a03dd320b52edac77519ddd780d0123217ae5d5f1211cefde4f6ed532231691eee1f14b24c11', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115466/', '', X'789c458d4b0a80300c44afe201bc849fb5146f90962c024d2b3129e2e985b6ea6edec09b71286ab731f8715850eda21aa782b1950e12a971830dc30f331608d4dd359f0a12bbcd54202954d8812d90f4012af91d46f692237de74c47f51f919d35ed', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115330, 'inotuzumab ozogamicin', 'tetrabenazine', 'Moderate', X'789c5d8ec18dc34008455ba18028bd447203ec803368c71001e3c85bfde244b944e280bef8efb1703afeb0e29f28c38607349c519b1147c2c36d98de31c5146c85ec0cb70544937dc77185a5b339a7341ce3b84033a44d54a2a8afce53b28355cd01efac1985c02c897ed8dfccd713ce314756064824293b03af2bb7eaa352e5cd1983095ce2f77c6c2fb64b9b034be4de8fec9b609c9763929c1af34062a879d8297ba36212b1568ad9afffa3f7651c', 'DDInter', X'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', 'Synergism', X'789c0dc8d10d02410805c0565e053661052636c0c9739704c1b0dc19addefb9cb9a6e8cbc25697b465209f689ed818f2b3203ed613d99305ad7d2cf494c64302ef4acf186710b73b2c9a758863cddc5d31182c71ff6223e44853eae50f6cdb2a0f', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115467/', '', X'789c7349ad2829cacf4d2dc9c82f2ac848ccd3517049cc494bcc2d28ca4cc9cc4bd55108ce4fc92ccd55c8afa84c4a2c01f28332734aabf273802ccfbcfc92d4a2e254a01ec7dc4c643d2189401e905d0c0091012307', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115331, 'inotuzumab ozogamicin', 'thalidomide', 'Moderate', X'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', 'DDInter', X'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', 'Synergism', X'789c1dcdd10985500c03d05532814b3849b1e5b5a0adb4bd4fdcdeab909f70205969b485c30ac47f2b615c2a8e56da8de33096d7c607d60acef1ab971b1b396a8f6b36810a6523a9059130e7b1093ab2682ecc9c61de325f32f56e3d8c96072c1c2dda', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115468/', '', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', X'789c3d8d510a83400c44afb207f012f55f94d20b8c1a4b603781b811e9e9bbd5d0bf3cde4c6622abfef182b94b2fc31e9056323f2b2d902e8d19867a672608b7330ad8b073c505e3cce2ff5f8fc20724d413c517b6dbf49443a4824d57addc36067db750e6a8f799e537a9170d6af40502523ebf', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115332, 'inotuzumab ozogamicin', 'tioguanine', 'Moderate', X'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', 'DDInter', X'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', 'Synergism', X'789c25cc410e83300c44d1abcc92554fd30b0432c5a6918d624794db17c4f67fe9bd85e81a5ff807c2bda42e50db463f11e2a355ccc4e2165ad95971080d29eaeb28a6466860c43d34059ec28edd93965a5a3b1fd3d37f975bd62b0726befe3b222c17', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115469/', '', X'789c458c510a83301044af9203e4162dfa65f1c30b6c9329045657860dd8db6b83a47fef31bc19b41aad5252d11866ac70e2408e610293ec6e7b65d910c3c2f2d18b73b341ede832624dc5e5dde40515defcf87ae799a2f23b176f7dcd7d7ae29f4f469c3de936a7', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115333, 'inotuzumab ozogamicin', 'thioridazine', 'Major', X'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', 'DDInter', X'789c158cd109c3400cc556791364894e50c802e6ece61ea476f0390964fa5eff84047a85e897ce5129c570c407d5194995876eb8591d51dd129ae73666954213c791b1876f5318de2be86579c90e0eb4f041b534fde35cd3954dca74f90197242ac0', 'Synergism', '', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115470/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115334, 'inotuzumab ozogamicin', 'tizanidine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115471/', '', X'789c258cc10d802010045bb100aa90b7b18605ce400277e4f4a157bda0bfddeccc7a6839a5ab24a96ed9b56762242d4c6ef1b98a9adc30997545ac72108fe11929101bfa4f6e746589d080366f3eb1918187f8021cf724e4', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115335, 'inotuzumab ozogamicin', 'tofacitinib', 'Major', X'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', 'DDInter', X'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', 'Others', X'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115472/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115336, 'inotuzumab ozogamicin', 'topotecan', 'Moderate', X'789c4d8f518e03210c43afe213f432db0b20f040b494a024b49ddb2fa37e6c3fadd8cef3bd11cb093d103a3598d3c04ba241a3d190cfd0d0b764a4ca110e7174f9653fb71f465f3d2003d59862fb1f27bbfa9a739f5c74a02c5ece548a843cf723839f8356c563b7ce96ec91b276ad5bf13898c36ff8e193460cae309d1c929046f9d219cee91be68320a35e14654334bcaea871aa05cb67ccffb6ab268bcf9e76e8f6074f4260c5', 'DDInter', X'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', 'Synergism', X'789c1dc8c91180300c03c05654014d5089c771883e3143148eee19d8e7ae36c5ece0809593230a58a1dc53e1f6fffcf2a21a522d0ef8a354de74d8165d6379016790196d', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115473/', '', X'789c35cbb10d80300c44d1553240b6000a3a0a94de312e4eb26c94b8404c0f8aa0bd7fafc0b8a1074c729aa8d28da04b34a702ab4a5fd988f50fbb184eef38de7d6d300f61b201bc89d60196f0ff333bcba00f7df627bf', X'789c458ccb09803010445b490136217af1e007b18151f6b09044d96c44ac5ec90adedecc3c6622d17ce780b5720d69beb8e0e82150abeb93bcd122489fed282862e248959b10f975cde90ef6fcf140db3fb47b5288b7ff3af089a8286146c81b8b69fd2ef4001fd536b5', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115337, 'inotuzumab ozogamicin', 'toremifene', 'Major', X'789c7590418ec3300845afc20146bdcb48b90032244663430524556e5fdc5977fbf97e0fbc99f3949d95a163407686a7256b0a0e4883a7db303d3e83df0d4493fdaa91ed9f8807b7746be8247638ce6a40d82c0aa614261eb0752e494ac331ee1f6886344525d2ab620a2fc90e5634073cd69322634243fd6a9f7883739c23970f8924e5aa6df6bdd60940a5ca9b330613b8c4dfdaf72ab64b3b0796c8bddfd9a7d4cdd51c27c9d298071203ad4f58b27f549c44ac9562f6c71b275d720a', 'DDInter', X'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', 'Synergism', X'789c0dcbc10dc2400c04c056b6029aa002241a30d8b9b3e47891cf09a27bf21d69ee14dd3d7d75493b13dcd02cdb7db3347cbd27d8d30a5ac758e8298db7243ec5608e0b0c8f273cdbea94c09a3c4231ae5d12f1c3cb20275d4d6f7fe4dc28d1', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115474/', '', X'789c73cc4b2c2e29caafcacf49d551702bcd294b057213f34a74147c52e1e28eb99979f9e939a525a9251999b999294021d78ad45ca0d2c4bc54004a671929', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115338, 'inotuzumab ozogamicin', 'trabectedin', 'Moderate', X'789c158cd115c2300cc456b9095882494cea92a3d4ee4bae946c4ff8d387a47bdab233d8d54ccc40ae98f8f0225f18b8a88a54f5067b7aa8638bbc024a3096b338aa1fa6547e59a881dd068ed4546972cc128d7dfb7fdffccc0de375b671fb0111e42e1d', 'DDInter', X'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', 'Synergism', X'789c25ccc10d02310c44d156e6c8896a68209b0cd810d92bdb116cf72ce2fabff46e4284e60b7e87706fa51d6acf1507527ccd818de86ea983c181b7d050d136f6e250832656fe8696c04b18d8bd68a56dcee36f7af9e774dbe3cc890baf5f35e32c01', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115475/', '', X'789c35cbb10d80300c44d1553240b6000a3a0a94de312e4eb26c94b8404c0f8aa0bd7fafc0b8a1074c729aa8d28da04b34a702ab4a5fd988f50fbb184eef38de7d6d300f61b201bc89d60196f0ff333bcba00f7df627bf', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115339, 'inotuzumab ozogamicin', 'trichophyton mentagrophytes', 'Moderate', X'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', 'DDInter', X'789c358ed10d02310c4357f102b00493846bda5af4d2aa4939b13de583bf48b6dfcba3d17850cce1b5af96f054c82553d133a22a460fb5a034e43e91a5b9b60f68ce62cc3cc402ffe0665a24f8564cf5d5c2715535483ab7c54327ad20518a750f1ef0170da11ed81416dd5f44c7d888addcf754094db818153ccfb5676b8ccdf69f43caaf75ff0235434a76', 'Others', '', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115476/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115340, 'inotuzumab ozogamicin', 'triclabendazole', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115477/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c0b284aacca2c2c4dcc2b49cdd151f0af48cccd037233f352017fbe09db', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115341, 'inotuzumab ozogamicin', 'trifluoperazine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115478/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115342, 'inotuzumab ozogamicin', 'triflupromazine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115479/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115343, 'inotuzumab ozogamicin', 'alimemazine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115480/', '', X'789c4dcdd10980300c04d0551cc02544ffd43f17d07a62204d4a2c623bbd2056fc7cdc71d7236aa40d52572342b2d993a0ae069cea10c9283f6e775673c971f12f6b9cd1391ff1c164144c99d64f6088bcb34d069766876b31f5618750b96d19bee4a31a6e566d3adb', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115344, 'inotuzumab ozogamicin', 'trimipramine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115481/', '', X'789c3d8cc10ac2400c447f656f5e16bfa21705b5a0e839b6290dc4a464a36cf7eba539f436f37833fd8c82dc4830a7eecb5ad1233f0c64e5615d4c3f019ec4d074d42df760bbd861f9a1304c50a3dffd98ce3acba1a4979ae774c5691f9e8a0e606fadd068cce956c98d160789ffc09b7651c33ffb4e3802', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115345, 'inotuzumab ozogamicin', 'tuberculin purified protein derivative', 'Moderate', X'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', 'DDInter', X'789c358ed10d02310c4357f102b00493846bda5af4d2aa4939b13de583bf48b6dfcba3d17850cce1b5af96f054c82553d133a22a460fb5a034e43e91a5b9b60f68ce62cc3cc402ffe0665a24f8564cf5d5c2715535483ab7c54327ad20518a750f1ef0170da11ed81416dd5f44c7d888addcf754094db818153ccfb5676b8ccdf69f43caaf75ff0235434a76', 'Others', '', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115482/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115346, 'inotuzumab ozogamicin', 'typhoid vaccine (inactivated)', 'Moderate', X'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', 'DDInter', X'789c6592418edb300c45afc25d5b603a8bf60483298a641760d0ee698bb189c89220524e32a7ef97d3a41874635822a9ff1fc97da24992548e4fe4b3d0af37fa2185ab2f929cf2910e6d883ad24e38fa4c2f6155cbf54aaf7959d45d8472a2fdb2b4a4efec8ac3a1f2e83a8ad1e797d7fde10b5519912c291814d849534f58d92550ae74d218f1b7f2386a42d520c461d1a4e65211f04c29a7afbbfd6fd2ae93ad9552c50cb10249f8344271ae41d3d4d33b87f12234350d12b757d9e808b179c3b83e0a9fe9276e772c4b2eb3c66670778c4dd23b0b0d77534f6419cfc9a54885d803e82f8fffe719b751d89cbed159e4d4a1a00e578ece769710fd4e4b4e3ec3da114514d4469c35b51e1f67380247e572a5f32c895ae7d5f40ff9ac98c72e87e9a4e993f57a28ca0da8f2a080fe689f9bcfb9aaf788b56912f8bb017c68abae489d36099b738be1be20f1ba71ae194d0d145aed464b06f205df06bcbb61b98c52fce69b07cbb1b9a03a09b6c218dbd347d1a7e455f8b1691b2fa10941fb22d9f31f5930f8b2', 'Antagonism', X'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115483/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115347, 'inotuzumab ozogamicin', 'typhoid vaccine (live)', 'Major', X'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', 'DDInter', X'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', 'Others', X'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115484/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115348, 'inotuzumab ozogamicin', 'upadacitinib', 'Major', X'789c2d8dc10dc3300c0357e102ed129d448d9558a8251996dcc0db3701fa2241e0782fa7a262123928c50dbe63762ab4495ef31ba7648567e501519de60ff8802e6e1eb3f7c111f265d0c19601a585ee7975a1645c1886c4e77e15db79bb15010a9cdcda9d6d69afae04b2f2d72835398c6c138ee70f42493ca3', 'DDInter', X'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', 'Others', X'789c658f514e04310c43afe2030097e0249d363313a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50ba70fc42d28f290eabd8905fc84da2939d40d3a31247ba352a4404fac9e4aca1a6a7a6c79cd7d37f0e9504bdfaea7c60d67f080b6b6ccdf41507b913157ef43e6d487205de4cd37ba735d65f7d95dba533deabf52b10e1979318254023b59db8fe7ed0899c11e2617af8cdec36a8a6dfde3fb5dd687eef1ce13c7d0f5831fa9bf3ebe00fc32708c', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115485/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115349, 'inotuzumab ozogamicin', 'ustekinumab', 'Moderate', X'789c65505d92c23008be0a07a8dec13bec05b0a10d63029d4074eae997581f74f7254cf8fe809f4cd08d4097284e37965ef10a0ff60cea991a70ad5dd4fab63532e37b701bd49dca570f571237a8b803cbdc08c333e4d0d86ec39c65a1d959c5ce7039b89ed15f822b81f12abcf08ce2653fdc4f23e77f78b8979e22509c85742b68cef33b7f82868971e44cf0e4a4f79e82354189f7a985d304a6f550b74cb1eba738f39a21a9c5dfc6d0b3b68035eed294938d813035127d03de74fb90a324282aeb29f8157c60585e5b48c642e9afdff917330290ca', 'DDInter', X'789c5550c98dc4300c6b85052ca689a944b1e54458db0a7c0dd2fd32c17ee6a78ba4c8b7cc615e611d1297758db084d987fe5a9d45361436d894b37b5771ca30ada3e373380e598aa681837c3d852d9e798334fdefadee184d65145ee163e3808f431bac9459bdcff36cda3b8137ae5c9abf66b1cdbdff406ac4b2a058dababcf0e6952264ab16243feb2c9b3719de2e14afc6e2964e24a51ca22e329fcf139ed0d9f2c5430b11d9770b7700e456684a1a689099d0811742224d6dfc1a713ea4b79ca44113d17af03a18963c4192fa3627e7f5fa03623c8357', 'Others', X'789c558bc10dc3300c0357e1004597e8244aacc64263d9906407d9be4ed14f7ebc23f9a21e5215e2a034c43941dee81efc11ed851694095878baab53340a610dc7912b320d86f13ac57efe828c39ab0632feb3e88630a62873854322a346668394d2b57a6fcdd87d1eaf5f3979bfb9647df307481386ac8cc1e6f4fc02fa8c4595', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115486/', '', X'789c458d4b0a02311005af92a5c25c425db970a35ea0d3d3388dfd0999b4104f6f50d15d150fea1d3a8aafc52b1b4d69678ddbd2d5b1374aac1ae637f11cc296361572e6b69dd2d591859fa190a774218c3bdb47cef088df72eae8652173614c803c8f830c0d904a1b582a290bac838f46f95fdc9384fa1a33cb5b58bf3daff402c77a40e6', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115350, 'inotuzumab ozogamicin', 'valbenazine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115487/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c7349ad2829cacf4d2dc9c82f2ac848ccd3517049cc494bcc2d28ca4cc9cc4bd55108ce4fc92ccd55c8afa84c4a2c01f28332734aabf273802ccfbcfc92d4a2e254a01ec7dc4c643d2189401e905d0c0091012307', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115351, 'inotuzumab ozogamicin', 'valganciclovir', 'Moderate', X'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', 'DDInter', X'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', 'Synergism', X'789c458ed10dc2300c055779035430067384d43416a91dd94e4bb727ad84f8bed3bdf748923957ddd8a0060e47339dad2f13b654973f9ee0457b9db19090a55a0f88069e84aceb938566ec1c051a850c67c191dc35738a1f5b0faaeabd352377564192f93e66855a310dfd70e638d0a50e8e111a79a1d7f92a190d3b86d0ae5e28b4c74ebc944b6c1a3470aa30f6b7dfbe172b529c', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115488/', '', X'789c3dcd410ac3300c04c0aff801fe44e8a1170702293de4b6b59520b0ad2052bf3faa4373db153b28a070fb26aee4dd04e503bb5263f5ee9929dee5455556b1e890b15235954c8c50d851a27743b16d455fcf5ce82fdf0622c72cbd2df8d11e1ff8c8419b5e2498b577571945e90408623844', X'789c458dcb09803010445b490136e1e7e2c1cfc10646d9c3421265b30962f54a12f0f666e6c1ac241a9fe8b037a6278d37675c2c045aea36912db40942b50d39850feca9312b3c7f6e71c68b2d579ee9f8878e120eae57c3191462cb59eb38c12b72984ea1171ebf36a6', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115352, 'inotuzumab ozogamicin', 'vandetanib', 'Major', X'789c5d8f516ec4300844afc201dabd4ba555ffa9216b540722c0a972fbe2ed7e55829fd1f066f844254e54f982865a3b83a19936d6744c317d273eb84c9a70b80dd3c75306db203bc3c71d4493fdc471837b67734e6938c6f5561ca45d54e285821fc90e56670ef828621402f399fc62ff67c28e1738c71c591a2091a49c0cbc6ddceabeea97de9c3198c025be57b173b597360756907bbfb2ef82b19c6392ac18f34062a8396c85fda162527d5a2a66bffd027a996a86', 'DDInter', X'789c4d8fcb6dc3400c445b99021c376104391b7603b4969208704987cb9591eeb38a72f089df7983b938952a262d8352dce03336b2c249260fbc245778ae1c28d197865c293191e119ae6ecb5830ae778825c7468ab67ad782858d83547ff060d0e652b89c713b8e194c59d9f29d7fbd7ffc3365600fb7a10dfeee125c4e7f4e95accf34658fa1089ebc0e4c69a81e8c79ffdda9d54dd263e78c38bbeef3f2056a78b1ea5e1b47af787a526bd2eb697017e3a31de147409dc600e58db59d7f01e3726cc2', 'Synergism', X'789c0dc8d10d02410805c0565e053661052636f04e709704c1b0dc1abbd7f99c6b525e16b6bad896817c6233449b61073ed613d9530b52e758e8c9c6838177a5678c7f286e7758b4d6a663cd3c5d3034b4e8fec5a1e04e1395cb0fdebe28bf', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115489/', '', X'789cf3cc4d2cc9cccb4cd25170494c2a4a4c4b05b31d93137380dc52b854727e6e269413925a900f65baa5a614c1b43b96251614c1d4f82416e59714a52643b9c1a939a5b9a9508e737e52268293580077806f7e512a008a1c33c6', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115353, 'inotuzumab ozogamicin', 'varicella zoster vaccine (recombinant)', 'Major', X'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', 'DDInter', X'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', 'Others', X'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115490/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115354, 'inotuzumab ozogamicin', 'vasopressin', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115491/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115355, 'inotuzumab ozogamicin', 'vemurafenib', 'Major', X'789c5d8f416ec3400845afc201dadca552d43d1d7006750c1630ae7cfb3269569560c117bcfff9e47d3a6eacf2050db57a0643336dace99862fa4e7cb052cd70b80dd3c75306db203bc3c71d4493fdc471837b67734e6938c6f5561ca45d54e285821fc90e56670ef828621402f3e9fc62ff67c28e1738c71c591a2091a49c0cbc6ddcea1e954a6fce184ce012df2bd8b9d24b9b03cbc8bd5fd977c1589b63922c1bf34062a83a6c99fda162527d5a2a66bffd0200196afe', 'DDInter', X'789c4d8f516a03310c44af320708b94428fd2ef4028a2def0a6c6991e494dcbeebfdca9746036f987918d5212a914e29a6b086178fe9d458e5893fc91d963b3baacf2d903b250a290eb76eba9d06e3e717a2c9fea20e09a8259c8b8dc15ab9def1f5f8066945b0cf01ee5cf2a4dfc9713bc1d2679533e9b0a40899e386419bf2921756a897cb8edd66af783286a9a439afa79d1791e4b9523edbafde74bcaf106ab946582cb84a93720dbeff03af646047', 'Synergism', X'789c0dc8d10d80200c05c055de042ee104262e50a14013694d29b8bedee7ed46b98bca08a7105358c1e23e9d0aab5c78251a2c1a3bb2cf3a108d0289148fdb6d5aff601c2744837dd10d19500b3827eb9d3573de3ea67c25d2', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115492/', '', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', X'789c45cd310ec3200c85e1ab70002e5165c9d02c4d2ee002519e04383206a9397da143baf949bf3e6f944a8d5c90add990e1e9e218ac7914c7f28633e4e0ad993f5e788f35053d40177c4fa623b2f07faf48e194d020d6bcb8d446454907bcd6b8931f5deedd939cdef002a5138db49fdd1edf29fdb885257c0134463a27', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115356, 'inotuzumab ozogamicin', 'venlafaxine', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115493/', '', X'789c3d8cc10ac2400c447f656f5e16bfa21705b5a0e839b6290dc4a464a36cf7eba539f436f37833fd8c82dc4830a7eecb5ad1233f0c64e5615d4c3f019ec4d074d42df760bbd861f9a1304c50a3dffd98ce3acba1a4979ae774c5691f9e8a0e606fadd068cce956c98d160789ffc09b7651c33ffb4e3802', X'789c458c4b0a80300c44afe201bc849fadda2ba4258b40d3424c8af4f482adba9b37bc1987a2568dc18fc3826a173d712a185be920911a37383c25fbfc190b04eab063f8bd359f0a12fb175381a4d040b1e6f88e1cb2971fb72c78033d8c3564', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115357, 'inotuzumab ozogamicin', 'voriconazole', 'Moderate', X'789c5d8e416e04310804bfc203a2fd478e91f603c43063141b5680279a7d7d98ac7289c4a9d55dc5bb5aaee79af809f6b41da73451987842c3150c0fb761ba638a29d806d9193eee209aec078e1bdc3b9b734ac331ce376886344525d25f9b6fc90e563307dc59330a815974fd63ff67feda9d638dac0c9048520e06de366eb547a5ca9b330613b8c4d7f5d8516c97b60696c8bd9fd9a7605ccdb1482e8d792031d43dec92bd50b188582bc5ecb71f329665a2', 'DDInter', X'789c6d905d6e03310884afc20972899ca0522e406cd68b6a43c54faae4f46557ad94873e1acf0cf37155ec8b853d0c8355403760d1c8572ebc83be74e0e2c602df1c3b68ec64d02d8743ec18d050e0cb74aa8c1a107cdcca1e640f9ce0bbe6ec3048c870ce27dc09f0a1dca95fe08a79ee43e9d0663568e5582a1c6a5c616804464dd7222903f0064da5de1c2801e974ecaea66fa9a076e8feefcf7e982aa80a172a49f83b93b17fc286add63b6c155424bf60e7612e702bbc85928728ad2c9e6390578cde038ba05ad3a416a60dadb30ec3e527a093e5fafb9ccfa01a5771742a723a254623275a5da9e7798030c228f8b8fc00d6f19e44', 'Synergism', X'789c0dcbd109c3300c05c055de045da21314ba8012abb6c0d60bb29cd24cdffc1edc935286b9cd0c49a3831f9833d7b5866ce0c52ac376737c2d1b984d0325569dc826895d1c47b0d3eb0d8ad7fbeea9714ac76c5cbda0aa6b48ef3f6c0a396945cbe30fe0b12d41', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115494/', '', X'789c734e2c2ec84f2bcd4bcfccd351f0cd4c4e84b11d730b32f24b528b329333f3149c74143c4b8a1293f3f312abf27352c12ae16cff92d4e25404d72da734b9b224bf38330fc871cccb4c29cd811a0a0071272809', X'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115358, 'inotuzumab ozogamicin', 'yellow fever vaccine', 'Major', X'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', 'DDInter', X'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', 'Others', X'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115495/', '', X'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115359, 'inotuzumab ozogamicin', 'ziprasidone', 'Major', X'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', 'DDInter', X'789c158cd109c3400cc556791364894e50c802e6ece61ea476f0390964fa5eff84407a85e897ce5129c570c4070f8f94410d37dcac8ea86e09cd731ba82e85268e23630fdfa630bc57d0cbf2921d1c68e133b734fde33cd3954dca74f9016bd72a5e', 'Synergism', '', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115496/', '', X'789c0bc9c8cc2fc9c8ac48cd4bd551f029cd4d2c492d482dca07f3f22b120b32412cdffc9cccbc14b0a0736251664151621558dca928b5a200cccdcf016b2f4a2cce04a90300712b201d', X'789c458b4b0a80300c44afe201bc44d5ad1fbc415ab20834166252a4a7175a3fbb79f3663614b5620cbeef4654bba8469731b672f574d837193043a007160ca4c60da6742a486cf71dd80249334eb1a4f89e1c538643a1c286ece5777312bc013d5b3559', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115360, 'insulin aspart (aspart)', 'acetohexamide', 'Moderate', X'789c4d8f610ec2300846afc201e62e613c08b66c233268288de9ed458d897f1bdefb5eaf86f564e51e8ec1a6601b20f4219be994e184f0e4388035df58e1c409cd82341883200e02e7fe7863c76cb6cb2c7432ae70934a2e73814a77168ebcae0b98a741d44642075568399aaebe006a4d9b75faee6175529437d03846f23e3f11dbc625919266744a81079721985b99dd0bb5e0bb64997de2fea20a60f97d71975172eb22f62467dda1fad8fbfa0212f8662a', 'DDInter', X'789c6552cb7143210c6c450578dc4326a7dcd28202f243639e4424b007571fe1971c929cd00776b52b5e71745601940ca9aa137c54d50c5b1d6965bb0a7735960dd00830dfd829431ecf5252cc3b0b7b377cc2e8057aa178871b49f733bc40d53b1964f528adbe8f7a5199751821a8014b545860c7091f04469f838df219de03728180171d35af66d2214e3506e81a37936ec20f5a94e0736f5d775f146536ddea4cb433065f2a800e8530632a7482cc8f070bb947687af7ef58c86e3afc4892ca6578483a4137dad54e50866c14e79df07a5c6a64def8901e19d6c6fd3b597ef6a09b092d339ee1edcf589ad2b085f14765b8d9197b38d89a69b3671c1350a0d4a5d4b04de0fd59e854e7b13a9560ebabcf06ad4ce7c428ff4dc4eaba9cfc5964f8d8f14ad0c2cde32bf8aae14d39ff1ef85eb85218c6b7b5f9589c86fc408fa4e023548677b1c454c24e9be72f9473e1af', 'Synergism', X'789c1d8cc10d80300cc456b90958824942134aa49293da94f9813e6dc9de65a63320a1288dc370345251db2c3fdd0c4f768f0ae906d1c78729742e55287a7bf8c82e6bc31379d9d749b5c8b1bdb4be23dc', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115497/', '', X'789c734c4e2c4aca2f4ed55108cecc2d4b2c2e492cc9ccd351f04b2c494dcfc9cccb4c01ca04e5179722a482520b12a15200b93d16bf', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115361, 'insulin aspart (aspart)', 'aloe vera leaf', 'Moderate', X'789c15ccd10d83210845e155ee045da29350447f1204a3d8c4ed6bdfcec397f30ee7e89ae489bd045111930c6346d99c0b1c9ea4aede401682af4c421343a78311299e4a29c847f09c11cd0e4b5786d42a9cffa1fadaa60ef282b86ede4a2d4a1fc90ba9ddc77afd001ba233d1', 'DDInter', X'789c3d4f5b4ec4300cbcca1c00ed59f8e1006ee26d46a476499ca2de9e6411fc599ef787052b0e6f8a2c219079c825acb2557d43921174033b245fec9af15dd420d5159736f9450e1a7b689bb037a9f546384e09aa4547d3a4bc683b687d54da24c1a36883ccf84cd9349820fb8b9e872ef9c4717acc17a5e23925b4d4545687c6fe097fa2dca7eff54e7a501e78ff0becc547cdd8740e3386af5ecb2015b15dfb34c27fe8a199495e239b7e0d363d96c7e30768c068de', 'Synergism', X'789c258ee1adc230108357f100e86dc30026395a8bf4ae4aae45dd9ec0fb67f9b365df3dd5b045375426c12978528d8f6637141ea9706880f5d4b08af76a0eb6309cd6f94f36b9465a9f383a5bbb90819d29f31ce8564ca77c817c1c4d3e43885cad8373be8a0f4b1570f9c5eb61dffae4d823a725363c67455ebaf1fba16bbc104facd71e4bbb8a6de2df07ebff4b94', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115498/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115362, 'insulin aspart (aspart)', 'lipoic acid', 'Minor', X'789c658e418ec2301004bfd20f58f8c31eb9f38189d389479a78ac780232afc7b02b2edc5aea56555f337d676812b3fe03b19ae5645a5d1324e98c4d3aaa074ba8041199c8bdfa6a3d711b232e0b53c01768698769819419be8b8d103aab4c2f3c641d8876c6ef97214bc34416b4ecf78270e85677bff1436c2c4d436f1afd4d5fed48de8823d4f421a15ec61646f9b74f1c6d1dc5cb89bb4646f44a5c2ef83bc4767e02be015ced', 'DDInter', X'789cd30500002e002e', 'Synergism', '', 'Minor', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115499/', '', X'789c3d8dc10a83400c447f251fb03fd14b4ba142a19e7a8b3a6a2066251b0bfbf7dd7ae86d98798fe9311d8b1e2113123db2f1cc6e3224bae632c1f21e70b1449d34aa0447a2fbf6cb239c4b732e65ced112b1ce9ce8a6b52d59695f61558723aa7334ee89e5c32aa7d3bb20d6aa3004c279136bed8b77ffffbdc546e21171ca5d767c0119103f0c', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115363, 'insulin aspart (aspart)', 'amcinonide', 'Minor', X'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', 'DDInter', X'789cd30500002e002e', 'Antagonism', '', 'Minor', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115500/', '', X'789c2d8ccb0dc0200c43576100a6a052d535f8446aa414a3341cd8be807af47bb6432ff4a27221efae5114196a3c09b9d46d68b4294ee9c6392eba0332d77fb392e221bb215b1f824436bbe25da02cdbeda92bdc148d51e7e907be4e2db4', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115364, 'insulin aspart (aspart)', 'amprenavir', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115501/', '', X'789c458d310e85300c43afd203f4161f36581062603325a048a1a92ae0fc3f8481cd76fc9c0e07dfd7ca99621829eba637d700c146d94eabc53d2a2cd414c30f8b9eb4bb8f61c653713919913889baeb8c4d286f6b2441a9e47a60290fe0efdad3775c372ad737dc6ba53ff9823858', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115365, 'insulin aspart (aspart)', 'bendroflumethiazide', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115502/', '', X'789c458c3b0ec2300c86afe203e412d0151654b1bb8e11bf94c491e356c0e969a7cedf63e63ad662032dd18c86cc3f2b9ae832c47c81100b72a2bb86db491f36d68d47701cdd8d254e13c11d1bc7fea8fd6da10e41a36ba2a9a065ae5f39a20952acc3ed93e8a975757e69c3b20fccf50f21523651', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115366, 'insulin aspart (aspart)', 'benzthiazide', 'Moderate', X'789c3d524172042108fc0a0fd84d3e92633ec028ab542958ead4eee4f56967b239090a6d37cd771692c743038783fc416a632f6ac416c967968e686a54de646a204e627350e58336a1a8554d479648db4141fa64b4c6bea7710352287b544bc4f368f8a09c506d1c213bb05012bc23f031a5bb465c44ddbb5c6f326677fc8630b97174a44deddea5088f059bbd57370127078989c2bc57364add9f33bf9f6fd4b218a428ffa809aadac21d53ed8a27e0046cb36e3abde3721cb5f1cc5eb55ea2ebd538f3b178be9171f375e7d1b8735203c88db834293a745bda1adb5f1cd9f8c7cbd287f3a511a53ac01a94e28daaa4532d0abc7290c92f7d133fa6abe16b4e9d5ffed84743227528cab5eee0c0839e52ca3a5be60e002f9e403bfa805d63b96a9832042f2d010296b91c3bc6f2e7c039dbb7bb1ff49d0523397d3cad5683430fe9424fc564b7e21e29951dd60984dae28e7d08bc23c7d26017e0c395e6a3494fe50852956fff5d80f4229d2d40a8c9f3ee3664d2b568205d2149e7a9cfe2a777921726d3379eeab624b52ef2d26563faeffaf805c96f0e20', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115503/', '', X'789c458c3b0ec2300c86afe203e412d0151654b1bb8e11bf94c491e356c0e969a7cedf63e63ad662032dd18c86cc3f2b9ae832c47c81100b72a2bb86db491f36d68d47701cdd8d254e13c11d1bc7fea8fd6da10e41a36ba2a9a065ae5f39a20952acc3ed93e8a975757e69c3b20fccf50f21523651', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115367, 'insulin aspart (aspart)', 'bismuth subsalicylate', 'Moderate', X'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', 'DDInter', X'789c6591417603210840afc2b27d6fdef410bd4017bd0055e2d02a58d0e44d4e1f2649575d89fa812fbe577582a6c2438da5c0490dc64690e94c557b2319a027d8f6aea5ee891a23b08351d216979932f0e9c88832d966714023488ab9b1b00fb2202e3c3660f1595916e86883d3ac68758fd3d80f8e36fec0309f515224612140c96f21642458815b47b6c36885cf507c1684ac7eb00df7007f27477fccdfd3c75d3eec50820d134c83550e7d9fde290dca2b7cfc75f74d67cdf015d9bd1b7b28e8fd65e05cc40f17f0bdf5a1cdff8de485d6b22eb011664c1b2d90f97a6521f7084d2ffe8c05a7130638a5902d308c9ac67a21fc79101ee1889f38e6543b0f3c9cfd75bd01cbb99dd8', 'Synergism', X'789c254edb0dc330085ce506a89a213a0932c441b2c1c24eaa6c5fa27edefb3ecda7a0bbe9f250abd83db00e01cb25cd47175bf01dc73dbcb6bb4857824e8414ef29b230747f1259c371d6090a4171e2aea67349a4e3abeb80da3c9bda0b836269391b45bb934dbc3467e6df467c91950c511590f19687428c1ab40fd2781ebd7fdde744d4', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115504/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115368, 'insulin aspart (aspart)', 'carteolol', 'Moderate', X'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', 'DDInter', X'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', 'Others', X'789c5d8cc111c2400cc45ad902027da40cc7b7010f179bb13dd4cff1e5ab91b43b1e74a6cc0d2a392c8a93daf6210eb6dc8e19fa621624090d2f1b4c0e949c4cf4531c1efe9fca9a76c17c194427a5af45102786c91a9be22d6d3febfe05d8933199', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115505/', '', X'789c4dcdd109c3300c04d05532409648be4de94717506cd108649d511c433a7d8b4342fff4eee014a892a138b63a0e53718a0a9324c6e3f0e05f2aefdcf11445242f27d663fbeba6c8f5d0b8423b67c954afcd9753bbeed9c53e50ca92b82bdfbf02372cbb41a15feedf3731', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115369, 'insulin aspart (aspart)', 'chlorpromazine', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115506/', '', X'789cf348ccc92f482dca4cc9cfd15108c8cc4d2c4bcc2b06f2f37414423232f34b32322b52f352c152f95599294096636e6671694e411198e3935f9158900952e09b9f939997920f62ba14c18c0400760522b7', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115370, 'insulin aspart (aspart)', 'chromium picolinate', 'Moderate', X'789c3d8fc16d43310c4357e1b1bda44157c8025d41b5f5ff17205bae2c1748a68f92a2b91104f1487e1de48d8aa9ed52506dd2ce13b6a11c6e4d56c3dbe7f98c56f68f4a5798a39933b6145497c67c474bff601d9036dc7e1955e89b2371c57ab829a85738d755187170ca9f25ce8d7bcc2749fa5c2afd99b34c24bb87bc30392993275cfe27d1184c3e1186a1d94ec8164e0cbae51b7d01b7d54b88fd91775dc5266385a8dce8e19fee7ed15e02', 'DDInter', X'789c458ed10dc2300c4457b90110b3f0c3006ee2369692b8384e11dbe32201bf3ebf7b77ef2e15eb342f6cc8e40432061d249596ca179c01ed2f3cc50bf642d62869d54d12b20eda784057a462da64368ca2b3662cd1919b7419cec61989a68bce515f908e9d5cb8fb80716239a46f711db346a406fd6ca158968516f6308526deafb87dc1bfa66917d7d3b1069b0af5735234fde0c6595280dac3f79862dc3e6d6fe8715f19', 'Synergism', X'789c1d8ec10dc3300c0357e10045b7c9008aadc4026c2b90e414d9be6abf3c82c76d86741ccba2b1a15210c818749374da3bbff003743df848345c8d6c50d1aea71454753ad9a1074a331db206bce9ea157b6ed421533cd8b8a2d00ad1e5fd814c5c14c2331cc685e5967966eaab275283febf503eab423b479a5293f5f71765f241cf', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115507/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115371, 'insulin aspart (aspart)', 'cinoxacin', 'Major', X'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', 'DDInter', X'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', 'Antagonism', X'789c1d8e510e83300c43afe203a01d623709adb7460a4d490b13b75fe1d3d27bb6dfe69ef1b52379277af1c3325622d9cc7661f3aac38319bfc2ca9381fdd0eae6951d12440bf614ba4e6438b2cacaa1094d86b28ebe80bd31a9d86cd30f46e1f578b4ccb06b419193085631e8d644639bde028f07ebf7e6fd44cd5e7f695740d5', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115508/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115372, 'insulin aspart (aspart)', 'clofibrate', 'Moderate', X'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', 'DDInter', X'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', 'Synergism', X'789c254edb0dc330085ce506a89a213a0932c441b2c1c24eaa6c5fa27edefb3ecda7a0bbe9f250abd83db00e01cb25cd47175bf01dc73dbcb6bb4857824e8414ef29b230747f1259c371d6090a4171e2aea67349a4e3abeb80da3c9bda0b836269391b45bb934dbc3467e6df467c91950c511590f19687428c1ab40fd2781ebd7fdde744d4', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115509/', '', X'789c4dcd410a83301085e1abe400b94451772d947a82890e38e0e4c96422eae91bbab1bb9f071faf5bb072f1d34825730c1f94ba537172c931bc6483b2156e3dec9269aa4a29869e0f37f8721a8e1f1b456ff536a43a618da163937b7f42c56993b981e1621795d4f2e1b0bf4b187f0177a13798', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115373, 'insulin aspart (aspart)', 'conjugated estrogens (topical)', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115510/', '', X'789c734aac4a4dc9afc84c4bcd4b05001eae04d5', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115374, 'insulin aspart (aspart)', 'copanlisib', 'Moderate', X'789c3d524172042108fc0a0fd84d3e92633ec028ab542958ead4eee4f56967b239090a6d37cd771692c743038783fc416a632f6ac416c967968e686a54de646a204e627350e58336a1a8554d479648db4141fa64b4c6bea7710352287b544bc4f368f8a09c506d1c213bb05012bc23f031a5bb465c44ddbb5c6f326677fc8630b97174a44deddea5088f059bbd57370127078989c2bc57364add9f33bf9f6fd4b218a428ffa809aadac21d53ed8a27e0046cb36e3abde3721cb5f1cc5eb55ea2ebd538f3b178be9171f375e7d1b8735203c88db834293a745bda1adb5f1cd9f8c7cbd287f3a511a53ac01a94e28daaa4532d0abc7290c92f7d133fa6abe16b4e9d5ffed84743227528cab5eee0c0839e52ca3a5be60e002f9e403bfa805d63b96a9832042f2d010296b91c3bc6f2e7c039dbb7bb1ff49d0523397d3cad5683430fe9424fc564b7e21e29951dd60984dae28e7d08bc23c7d26017e0c395e6a3494fe50852956fff5d80f4229d2d40a8c9f3ee3664d2b568205d2149e7a9cfe2a777921726d3379eeab624b52ef2d26563faeffaf805c96f0e20', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115511/', '', X'789c73cd2b294a4d2ec9cccb4cd251f0cc4d84b2028a12738a53a11cc7e2e4cc5c283339312731a9a8142ae392989c9f9b09d3935a9199925804e3252617c16442520bf2a14cb7d4942298258e6589057035bef945a9003a313323', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115375, 'insulin aspart (aspart)', 'demeclocycline', 'Moderate', X'789c35cbc10d84300c04c056b682ab860672d626b10436c20e3a777f7cf8cd6736e6d5a4645763e06805da6c26444e62d6e9632fe1a102f64e4978875aac27e05b0fe5620bb581d48845042d34f5d62ca4833f1f345ff1aecf1ff32f2c1c', 'DDInter', X'789c4590415204310845afc252abbafa109ec085176012eca0e91081389539bd6474ca55a8f0f9bccf4b15c970d491c408acc8a8192e04a7347651ca906a74ea846ba146dfa4e0e48a69a6ca8d0c5009ba9225e54ba85da0a33335379006dc6c846e03b24e89b18611bf83179af749aa9934fe44a1e0378152c30a7c76643dc36487b7420f17c86278041bce107e0d0e03cc1fc37c49972fae8d4e81e7bcb61bd8588b9df20eaf0faeff94d8bbb205b6dc99c0f86811a965b0797697d356a7cc2e479d894e4678a2fdd83728841953a10d32df6eeb1216a5cad5feea86c3084338da41ba812b9d12ef95f0f35761513ab7638b8bd5ce8e8bd99e6344aeeb8e318191cab73b507c24691ec916292bf4328de3a46d0567074969a8ed3f9687ab57', 'Synergism', X'789c1d8cc10dc3300c0357e1004587e8268acdd60214cb90e514d9be46bfe4ddbdccbde263abf82466f3651507717ad7f46045b1fdd88d6f63e7c5403243ca5d4c3b272488119c25f4d8743a86a4b2e78477689f6b730f700e1615db217d231befbf49ab8cbd79a0c94504bb18f41ca271eec8f3070e4f3c2c', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115512/', '', X'789c458c510a83401043afe201bc442dd2af2ab4bd4018470dddd99541456f5fba82fee591977c38a8ec1218b52cdef00b5a4387936ac77ad17399e84918cbe2c51eb6e75841383b72be8f21396c1a35525238bc8df6ef1e1a6718b377337e8f45a329fffc0054aa352b', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115376, 'insulin aspart (aspart)', 'deserpidine', 'Moderate', X'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', 'DDInter', X'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', 'Synergism', X'789c35cfd16dc4300806e055fe01aa76884e426dce41c560617255b62f39e9de40c0077cab6fc67493f4101b7878200f46e727abafc996f0078e6bf9d0abf114826c04379f55ecdcf177b061f9ce413654ca6aa01e6c1ca3c21ff5f67bd3340adba06034a73ec56427c72d481e10dba78aa10e78879b5b70d2f071f2fec0a24869a752e8553d95a7bcc8d73cf527592badf680ac7f1554479042e62289fb95cf7f23fa5b2d', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115513/', '', X'789c0b284aacca2fceccd351f0a84c294acc49accacc4bd551702f4dcc4b4b4c06b37d534b322a7352f20b1201801810be', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115377, 'insulin aspart (aspart)', 'dexamethasone (topical)', 'Minor', X'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', 'DDInter', X'789cd30500002e002e', 'Antagonism', '', 'Minor', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115514/', '', X'789c458dc10ac3300c437fc51f909fd80a633b94de7a374e1802270eae73d8df2f2b1bbb497a125a205a0e6bc825d13a3adc042dd175e47f6cb5044f37f54d47c3617a824dad7370c687ec08ae6874394b01f92e1edd39dc3a464db4b8557b2a04422cc889ee2fd6e1f3e917ace6e50d16f33635', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115378, 'insulin aspart (aspart)', 'dexfenfluramine', 'Moderate', X'789c2d8ecb1102310c435b51010c075aa1829068b386fc70bc30e91e0f70f4e849cf5769917853f26e287d4ed4b010b68dd190cb8aac12117b33ed05a12578411926613ba1321fe81bf635fa9f0e4ec0d6202e48126e34fa284b113be6092398b0d98432525ed2b2af763fcc3d498ffcfb40f93c448941959e3c0ae97e4cabdfaa0b5d2eea4d939fc3894ae77cbdb779fe00c55250ae', 'DDInter', X'789c4d50d1914321086c8502dea488abe05a204a94898a03789997ea0f937ce4cbdd61d95dfc6922194a5b498cc0aaac96e14a905af0764297c12e4a19f2521e051ec4a53ac4d8c095d03b0d3f0047069c53652aa3c77ec551c8a063267001af141ae7cc7825e704595701a5c2b10f68308832e50bfca27338da5797edcb1615e4f6f20972dfb89e534a3b1375c65781ad6da4be03a778d83036302ec35e733bfb74e9e1bd52dda1953063aa7440e6e7930799055479d8070fd23f59f62649c66d19cb38f6e55df480bae2ca781f84f7b76892da648d2bb66e629bec1fb22b78c49d0935fee1f20f26f18d2e', 'Synergism', X'789c0d8bd10d43210cc456b901aa0ed14df2c80922014121a8eaf6e5d3b2fde9ee8ada4ff14dece6a72b1ea2f4cbfd87e1d3d2830a3d61b3e24bab2d71f54606250767be2053216b85af30c9fb3799951b4394484736de264d4d1ea615689c8a60b5fb433626a9d4f71f560935a6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115515/', '', X'789c732a2d28ca2fc8cccfd351f04bcc29294aadc8cf4b050058a9082b', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115379, 'insulin aspart (aspart)', 'dienestrol (topical)', 'Moderate', X'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', 'DDInter', X'789c2d915176c5200844b7c2027ade26ba816ec12889f428a480e973f7c534bfccc865c6cf2686901b31e5d4a00b938b121f203b1c6d66ec94210bbb4a033250ccd23b72c102bbb426bfcb1ccf9d9293308842215b2f88c733dac12b06a7e838ec031297358022960eb4a5873ff69227f6909d0aa50d3dd061603748e57b980733193066344b3a5ff015805bb72aa315d8309c1759185d80c5699f0b450a679d46991203edcf686b2225528ebc4a887071855160d8db844a475d69feed13f07da2062d23d8eca74bbf2f37bc5011ea0cf5292c818d5cd7a9f85ea7d285b182d4fc8e4e9c15934570e2bb874bdae8b858bbe2cf08c45c9b47fcc35de0eb0f79019edf', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115516/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115380, 'insulin aspart (aspart)', 'diethylstilbestrol', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115517/', '', X'789c73ca4c4ecc292d49cccd4c49d551704aac4a4dc9afc84c4bcd4b050083aa09e5', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115381, 'insulin aspart (aspart)', 'diflunisal', 'Moderate', X'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', 'DDInter', X'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', 'Synergism', X'789c254edb0dc330085ce506a89a213a0932c441b2c1c24eaa6c5fa27edefb3ecda7a0bbe9f250abd83db00e01cb25cd47175bf01dc73dbcb6bb4857824e8414ef29b230747f1259c371d6090a4171e2aea67349a4e3abeb80da3c9bda0b836269391b45bb934dbc3467e6df467c91950c511590f19687428c1ab40fd2781ebd7fdde744d4', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115518/', '', X'789c734c4e2d49cccdcccb2fc848cdd35188ca4ccecfcb2fc94c49d551f04d2dc9c8afa84ccb292d4acc4b050046300fc8', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115382, 'insulin aspart (aspart)', 'dobutamine', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115519/', '', X'789c7329caafc84cc92f48d451f005d229459979a93a0a8eb9403a1fccca4bcfcc2f49cd2bcecc53f0f40429ca814b1525959624e68235b8a5e6e5e7808cc90500a9311d32', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115383, 'insulin aspart (aspart)', 'enoxacin', 'Major', X'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', 'DDInter', X'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', 'Antagonism', X'789c1d8e510e83300c43afe203a01d623709adb7460a4d490b13b75fe1d3d27bb6dfe69ef1b52379277af1c3325622d9cc7661f3aac38319bfc2ca9381fdd0eae6951d12440bf614ba4e6438b2cacaa1094d86b28ebe80bd31a9d86cd30f46e1f578b4ccb06b419193085631e8d644639bde028f07ebf7e6fd44cd5e7f695740d5', 'Major', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115520/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115384, 'insulin aspart (aspart)', 'ephedrine', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115521/', '', X'789c4dcadd0980301003e0553a4097504104f1491728e781076d53fab3bfa788fa962fc9cc1519de91351382ab1949225bd3bd6925243d841b0bd7a3fc8bedba9162570c429e0be28da525c92089d6f46dff6a04ae4ea579f42d4a817f86cc279aed3407', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115385, 'insulin aspart (aspart)', 'eprosartan', 'Moderate', X'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', 'DDInter', X'789c6591417603210840afc2b27d6fdef410bd4017bd0055e2d02a58d0e44d4e1f2649575d89fa812fbe577582a6c2438da5c0490dc64690e94c557b2319a027d8f6aea5ee891a23b08351d216979932f0e9c88832d966714023488ab9b1b00fb2202e3c3660f1595916e86883d3ac68758fd3d80f8e36fec0309f515224612140c96f21642458815b47b6c36885cf507c1684ac7eb00df7007f27477fccdfd3c75d3eec50820d134c83550e7d9fde290dca2b7cfc75f74d67cdf015d9bd1b7b28e8fd65e05cc40f17f0bdf5a1cdff8de485d6b22eb011664c1b2d90f97a6521f7084d2ffe8c05a7130638a5902d308c9ac67a21fc79101ee1889f38e6543b0f3c9cfd75bd01cbb99dd8', 'Synergism', X'789c254edb0dc330085ce506a89a213a0932c441b2c1c24eaa6c5fa27edefb3ecda7a0bbe9f250abd83db00e01cb25cd47175bf01dc73dbcb6bb4857824e8414ef29b230747f1259c371d6090a4171e2aea67349a4e3abeb80da3c9bda0b836269391b45bb934dbc3467e6df467c91950c511590f19687428c1ab40fd2781ebd7fdde744d4', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115522/', '', X'789c73cccdc94fc92cc8cc4bd551084e4c2e4dca2c29caccd15170ccc92ccece2c4acd0300cf880c4f', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115386, 'insulin aspart (aspart)', 'ertugliflozin', 'Moderate', X'789c358e310ec2301004bfb265222529f2050a1a3af8c0e11cf609db17d96721ff1e53d0ee6867f7a27424c952ad908966e80b84aa87b4b4fad89c5686d375e05c4f2dc6053ba6fbf5f658f71992833cc5b4e02316407924b545c9a8ec0a1b79f58d31f1e6b70583bc34f7d80ad382c43e8a8ded83670cc3bf99a8e354e36c42c6b0c02852dfbf67a19fea63779c84b62f07ef4465', 'DDInter', X'789c3dc9310e83300c46e1abfc1768076ed0a94b37b8800326b104b6701c45bd3d99d89edef7c1619d1d9b55ca0cdb1185215adb218acaab7350b6dc86f9f34ffa23319caf26ce1b7a6145aba306ae7626510a3145972820c5fcfd2daf6968912461febe0166412b8d', 'Synergism', '', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115523/', '', X'789c734c4e2c4aca2f4ed55108cecc2d4b2c2e492cc9ccd351f04b2c494dcfc9cccb4c01ca04e5179722a482520b12a15200b93d16bf', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115387, 'insulin aspart (aspart)', 'escitalopram', 'Moderate', X'789c8553416edb3010fcca1e1dc0492fbdf594063de4501448f2019a5a518b505c96a4ea28afef2c63a7560ab4179b14b9333b33cba789695ab386b87a9ec5138f23fb463a92a4ba444934bb950e4c591ba726aef14087953c97e6703a9425d43d2efbb80c9202ddde7dc36e9283342d3871298895565c2eec39e3331da2fa672e9576b70f5febd59e3e5fbb5992fe5cf00352b6c279357a975cd4d081dc01679e6ae3a232e0d328878286b09a35a92130e98b0caef2450fb4fb7efbe37ed3a451bc026c007575005de31b4ee508f9f28bb12ada34f5ae97dcdcf316f2f1f1e1de1a8747a326500f563e48d5bc96bedd532e9af565cd1327ec4c9b80fdbcb4854b030518cd29dcd0d3c4e8bb1bda4d47bb854d4a434845eab3a5721196b31c384d2e79d374ceab9ad790206d85bd1fd230bb2f7d3b915f7d81ab322f70610b850e9a68a2ddc6a50f323117707d5c63eca2fe2ffb94c71ff281bbd44b6e1fd91548e36e52e12ab5f5edeeaf5901c0c92b03c85c04dcc5450a71f10a039726515edd9b929edcfecc731d05c986a2c736d1e83c6cea70dd3283eb188935400d7a78af7f9fa97fc0d4a847c3e801c23a0b30b8da8a3db439b7d50e77db414719047fc223a94bced0fd264a6bcbb06390932c177493cf07901bbac3563c6e6f266672158f996da8b3167bcbc3528c60a9bdbbaa73ff6f7d161d44b74a80b48755e82850770ee8d4e57656d05658b8defc06209499e9', 'DDInter', X'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', 'Synergism', X'789c254edb0dc330085ce506a89a213a0932c441b2c1c24eaa6c5fa27edefb3ecda7a0bbe9f250abd83db00e01cb25cd47175bf01dc73dbcb6bb4857824e8414ef29b230747f1259c371d6090a4171e2aea67349a4e3abeb80da3c9bda0b836269391b45bb934dbc3467e6df467c91950c511590f19687428c1ab40fd2781ebd7fdde744d4', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115524/', '', X'789cf34d2c28ca2fc9ccc9cc4bd551082ed153f0cacfc8532f5608cf2f2ad151f0cdccc94b4cce2c284accd351f0492dcbcf451670c9af482dc804314a7380cc12b01961994076621598ed980b641680999eb9204db960b66b71766a0994ed925a8c90f0cd2f4a0500d5fe343d', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115388, 'insulin aspart (aspart)', 'esmolol', 'Moderate', X'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', 'DDInter', X'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', 'Others', X'789c5d8cc111c2400cc45ad902027da40cc7b7010f179bb13dd4cff1e5ab91b43b1e74a6cc0d2a392c8a93daf6210eb6dc8e19fa621624090d2f1b4c0e949c4cf4531c1efe9fca9a76c17c194427a5af45102786c91a9be22d6d3febfe05d8933199', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115525/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115389, 'insulin aspart (aspart)', 'esterified estrogens', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115526/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115390, 'insulin aspart (aspart)', 'estradiol (topical)', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115527/', '', X'789c2d8ad10980300c0557e9009d4291fe89080e10682a8198485aa138bdadf4efdebd9be0c5a895120a7ab719e482a69d0fa6db281760ef5635e4137331bd48da8604cd745c184e65aadecdd8ee6e1b07101ab8233fa3082a10ff443e81ce2c5b', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115391, 'insulin aspart (aspart)', 'estramustine', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115528/', '', X'789c358c410a02311004bf9207e4131e3c781045fd409b6d6460325992892c79bdc9c153174d517756efa367bc63b82976545974406557b8580c8f9efeff4b1a3e346552f6448de194c58af2db554c5240926d6a18ccf4d21c3e15f54ac71419c3e5c02879b59ec54b455b78b6b91b6df1b554fe001e34369e', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115392, 'insulin aspart (aspart)', 'estrone', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115529/', '', X'789c734aac4a4dc9afc84c4bcd4b05001eae04d5', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115393, 'insulin aspart (aspart)', 'estrone sulfate', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115530/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115394, 'insulin aspart (aspart)', 'estrone sulfate (topical)', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115531/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115395, 'insulin aspart (aspart)', 'etacrynic acid', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115532/', '', '', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115396, 'insulin aspart (aspart)', 'ethionamide', 'Moderate', X'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', 'DDInter', X'789c6591417603210840afc2b27d6fdef410bd4017bd0055e2d02a58d0e44d4e1f2649575d89fa812fbe577582a6c2438da5c0490dc64690e94c557b2319a027d8f6aea5ee891a23b08351d216979932f0e9c88832d966714023488ab9b1b00fb2202e3c3660f1595916e86883d3ac68758fd3d80f8e36fec0309f515224612140c96f21642458815b47b6c36885cf507c1684ac7eb00df7007f27477fccdfd3c75d3eec50820d134c83550e7d9fde290dca2b7cfc75f74d67cdf015d9bd1b7b28e8fd65e05cc40f17f0bdf5a1cdff8de485d6b22eb011664c1b2d90f97a6521f7084d2ffe8c05a7130638a5902d308c9ac67a21fc79101ee1889f38e6543b0f3c9cfd75bd01cbb99dd8', 'Synergism', X'789c254edb0dc330085ce506a89a213a0932c441b2c1c24eaa6c5fa27edefb3ecda7a0bbe9f250abd83db00e01cb25cd47175bf01dc73dbcb6bb4857824e8414ef29b230747f1259c371d6090a4171e2aea67349a4e3abeb80da3c9bda0b836269391b45bb934dbc3467e6df467c91950c511590f19687428c1ab40fd2781ebd7fdde744d4', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115533/', '', X'789c3d8c410e83300c04bf9207e415443d22a1c2070cb8c252121be31cc2eba128ed697767a509208a9cea42d9bba12a9c9421d18adebde903ede87085bd50a4dcb860b6678ca628f6134c4a096d63b9b309849e27d425f281fa37ccc5befc651ba4bb73f4ae67c50b1afd3509', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115397, 'insulin aspart (aspart)', 'etonogestrel', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115534/', '', X'789c0bcdc92c28ca2c2e49ccd151f0cb2f4acd494f2d2e29cacfcdcc030088be0a4e', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115398, 'insulin aspart (aspart)', 'everolimus', 'Moderate', X'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', 'DDInter', X'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', 'Antagonism', X'789c2d8dd10d0331084357f1005597b84968e052aa04a4c0a9baed4ba4fedacf7ec7f010b4a1a68d06a69ba62fb50e3fd1c7dd646a4373cbe5031a58d27c4e3116c6e963f877c3354fa55437f8026bec85daf58f4ee45bcac3ebeaf10019ef00ec415d62f7c5d7af2659569dca4a2fc95217601920fe5c91e5a4804993085af7f307e32e47d6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115535/', '', X'789c73cd2b294a4d2ec9cccb4cd251f0cc4d84b2028a12738a53a11cc7e2e4cc5c283339312731a9a8142ae392989c9f9b09d3935a9199925804e3252617c16442520bf2a14cb7d4942298258e6589057035bef945a9003a313323', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115399, 'insulin aspart (aspart)', 'exenatide', 'Moderate', X'789c658f310ec2300c45aff247185aa967606061e00a6962528bc48e1257556f4f5b040cacfefecfcf177521b370b3ea8c55a00f38c4347b1755bac44f42a1621ca81b70badeeedd704625bfcdb4625fdaba58d826b0b439b120bb15458dc4d819c12642e5f6dcd1d35a34a6d55366d7e3a0fdc11a922e543126d570a868238c2b9a719ed3a629f17bab91af74883b09efe21e7f1ef8e5fd0b33155685', 'DDInter', X'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', 'Synergism', X'789c35cc310ec2400c04c0afec030812afa0a1a0a376f092583aec60df09e5f7a4a11e691e2b1d82ebed3e5d907c72eb919025dcaac30aa3a89082a84ee1e82b53b61d3d304b4983798d667e3a92165f26344a16225e7fc25b76cc3cf6cfb0a49e7f3cd12924', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115536/', '', X'789c734c4e2c4aca2f4ed55108cecc2d4b2c2e492cc9ccd351f04b2c494dcfc9cccb4c01ca04e5179722a482520b12a15200b93d16bf', '', 1767369485, NULL, NULL, NULL);
INSERT OR REPLACE INTO drug_interactions (id, ingredient1, ingredient2, severity, effect, source, management_text, mechanism_text, recommendation, risk_level, type, metabolism_info, source_url, reference_text, alternatives_a, alternatives_b, updated_at, arabic_effect, arabic_recommendation, ddinter_id) VALUES (115400, 'insulin aspart (aspart)', 'fenfluramine', 'Moderate', X'789c2d8ecb1102310c435b51010c075aa1829068b386fc70bc30e91e0f70f4e849cf5769917853f26e287d4ed4b010b68dd190cb8aac12117b33ed05a12578411926613ba1321fe81bf635fa9f0e4ec0d6202e48126e34fa284b113be6092398b0d98432525ed2b2af763fcc3d498ffcfb40f93c448941959e3c0ae97e4cabdfaa0b5d2eea4d939fc3894ae77cbdb779fe00c55250ae', 'DDInter', X'789c4d50d1914321086c8502dea488abe05a204a94898a03789997ea0f937ce4cbdd61d95dfc6922194a5b498cc0aaac96e14a905af0764297c12e4a19f2521e051ec4a53ac4d8c095d03b0d3f0047069c53652aa3c77ec551c8a063267001af141ae7cc7825e704595701a5c2b10f68308832e50bfca27338da5797edcb1615e4f6f20972dfb89e534a3b1375c65781ad6da4be03a778d83036302ec35e733bfb74e9e1bd52dda1953063aa7440e6e7930799055479d8070fd23f59f62649c66d19cb38f6e55df480bae2ca781f84f7b76892da648d2bb66e629bec1fb22b78c49d0935fee1f20f26f18d2e', 'Synergism', X'789c0d8bd10d43210cc456b901aa0ed14df2c80922014121a8eaf6e5d3b2fde9ee8ada4ff14dece6a72b1ea2f4cbfd87e1d3d2830a3d61b3e24bab2d71f54606250767be2053216b85af30c9fb3799951b4394484736de264d4d1ea615689c8a60b5fb433626a9d4f71f560935a6', 'Moderate', 'pharmacodynamic', NULL, 'https://ddinter2.scbdd.com/server/interact/115537/', '', X'789c3d8d410e83300c04bf9207e415a0de4a4f7c60432d622989236310edeb1b22d4db6a67563bec55a5b214ef5e48a6744a21ef06e5038a850cd9bbb9198a0c6be4f19515812f69a422e1ae9fc862ca6b071359fca41a3bd7c086d4861665db4fcefceefe221bee4c0719ffdf2651fa0187883799', '', 1767369485, NULL, NULL, NULL);